Skip to main content
Thoracic Cancer logoLink to Thoracic Cancer
. 2023 May 1;14(18):1668–1706. doi: 10.1111/1759-7714.14912

Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data

Fatemeh Rezaei 1, Afrooz Mazidimoradi 2, Ali Rayatinejad 3, Leila Allahqoli 4, Hamid Salehiniya 5,
PMCID: PMC10290923  PMID: 37127553

Abstract

Background

This study aimed to describe the trends in incidence, mortality, and burden of tracheal, bronchial and lung (TBL) cancer in Asia from 2010 through 2019 and compare with global and other continental data.

Methods

We collected TBL cancer data from the 2019 Global Burden of Disease (GBD) study from 2010 to 2019 in 49 countries and territories in Asia. For all locations, annual case data and age‐standardized rates (ASRs) were used to investigate the incidence, prevalence, mortality, and disability‐adjusted life‐years (DALYs) of TBL from 2010 to 2019. The relative difference (%) between years was used to show comparative variations of ASRs for the indicators studied.

Results

In 2019, more than 55% of TBL cancer cases and deaths occurred in Asian countries. A total of 57% of lung cancer patients lived in Asia and almost 60% of the global burden of lung cancer was imposed on Asian countries. From 2010 to 2019, incidences, deaths, prevalence cases, and DALYs number of TBL cancer increased over 1.34‐, 1.31‐, 1.31‐, and 1.26‐fold, in Asia. During this period, the age‐standardized incidence rate (ASIR), the age‐standardized death rate (ASDR), the age‐standardized prevalence rate (ASPR), and the age‐standardized DALYs rate (DALYs ASR) of TBL cancer decreased by 1, 3, 4, and 4%, respectively. While at the same time, the decreasing trend of these rates globally and in America and in Europe happened faster. In 2019, age‐specific incidence, death, prevalence, and DALY cases of TBL cancer were peaking at 65–74, 70–74, 65–69, and 65–69 years, respectively. In 2019, the highest ASIR, ASDR, and DALYs ASR of TBL cancer was observed in East Asia countries and the highest ASPR in high‐income Asia Pacific countries. Central Asia and high‐income Asia Pacific countries experienced a decreasing trend in ASIR and ASDR, and the South Asia countries experienced the highest increasing trend from 2010 to 2019. ASPR only decreased in Central Asia, and DALYs ASR only increased in South Asia. In 2019, among high sociodemographic index (SDI) Asian countries, Brunei Darussalam had the highest ASIR, ASDR, and DALYs ASR and the Republic of Korea had the highest ASPR. Among high‐middle SDIs, Turkey and Georgia; among middle SDIs, China and Armenia; among low‐middle SDIs, Mongolia and the Democratic People's Republic of Korea had the highest ASIR, ASDR, ASPR, and DALY ASR of TBL cancer. Among low SDI Asian countries, Pakistan had the highest ASIR, ASDR, ASPR, and DALY ASR of TBL cancer.

Conclusion

Most of the global burden of lung cancer occurs in Asian countries, and the decreasing trend of incidence, death, prevalence, and burden of this cancer in these countries is slower than in other regions. Therefore, the implementation of necessary measures in order to reduce the process of this cancer is considered urgent.

Keywords: Asia, bronchus, burden, incidence, Lungl, mortality, prevalence


In 2019, more than 55% of tracheal, bronchus, and lung (TBL) cancer cases and deaths occurred in Asian countries. A total of 57% of lung cancer patients lived in Asia and almost 60% of the global burden of TBL cancer was imposed on Asian countries. From 2010 to 2019, the age‐standardized incidence rate (ASIR), age‐standardized death rate (ASDR), age‐standardized death rate (ASDR), and age‐standardized DALYs rate (DALYs ASR) of TBL cancer decreased by 1, 3, 4, and 4%, respectively. While at the same time, the decreasing trend of these rates globally and in America and in Europe happened faster.

graphic file with name TCA-14-1668-g005.jpg

INTRODUCTION

One of the worldwide leading causes of death is cancer and its burden is not consistent. 1 Particularly between developing and developed countries, the incidence, mortality, and disability‐adjusted life year (DALY) burden of cancer vary considerably across countries and regions. 2 , 3 , 4 , 5

Globally, TBL cancers are among important public health issues and the burden of these cancers varies in different countries. 6 , 7 In the past few decades, lung cancer has been the most common malignancy and cause of cancer deaths. 8 Furthermore, lung cancer remains the leading cause of cancer‐related deaths in men and women 9 and an important public health issue due to a 5‐year survival rate of 17.8% 10 and a high fatality rate. 11

According to the latest GLOBOCAN estimates of cancer incidence and mortality in 2020, a total of 2 206 771 new cases were estimated, accounting for 11.4% of all new cancer diagnoses. 12 In addition, according to the Global Cancer Observatory: Cancer Today statistics by the International Agency for Research on Cancer (IARC), after breast and prostate cancer, lung cancer had the third highest incidence and mortality in Asia in 2020. 13 In 2020, the Global Burden of Disease (GBD) study reported that the worldwide healthcare burden and costs attributed to lung cancer are significant. 14 In males and females, the age‐standardized cumulative lifetime risk of lung cancer diagnosis is 3.8% and 1.77%, respectively. 7 , 13 In Asia, the highest age‐standardized rate has been shown in Turkey and the lowest age‐standardized rate in Saudi Arabia. 15 , 16

Lung cancer has several risk factors. Nonmodifiable risk factors include; age, gender, family history and race/ethnicity, and modifiable risk factors include; tobacco smoking, cannabis smoking, asbestos, radon, arsenic, air pollution, infection, and chronic obstructive pulmonary diseases. 17 Lung cancer is more prevalent among men, individuals >60 years old, African Americans, and people with a positive family history. 17 Tobacco smoking is the most important risk factor for lung cancer, and 81.7% of lung cancer cases and 81.3% of lung cancer deaths are closely related to cigarette smoking. 18 In smokers, the relative risk of lung cancer is about 20‐fold higher than in nonsmokers. 19 On the other hand, the worldwide incidence of lung cancer is on the rise with increased industrialization. 20 In this study, the trends of incidence, mortality, and burden of TBL cancer in Asia from 2010 through 2019 based on the sociodemographic index (SDI) are described and these data compared with the trend in global and other continents.

METHODS

Source data

The annual data for 49 Asian countries and territories and six GBD regions, global and continents in the context of incidence, prevalence, death, and the burden imposed by TBL cancer were extracted from the GBD 2019. The GBD 2019 were accessed via the online data source Global Health Data Exchange (GHDx) query tool (http://ghdx.healthdata.org/gbd-results-tool) based on the International Classification of Diseases 10 (ICD‐10) (code [C56.9] for TBL cancer). GBD estimates all available epidemiological data (incidence, mortality, prevalence, year of life lost [YLL], years lived with disability [YLD], and disability‐adjusted life years [DALY]) by time, location, gender, and age group for the comparative assessment of health loss due to 364 diseases and injuries across 204 countries and territories from 1990 to 2019. 21 , 22

In this study, data were extracted for various classifications of Asian countries on the basis of a sociodemographic index (SDI), and six GBD regions of Asia from 2010 to 2019 and compared with worldwide and other continental data. Specifically, we used data for North Africa and the Middle East, given that 15 out of 21 GBD countries in North Africa and the Middle East belong to West Asia. In Southeast Asian countries, two were also from Africa.

GBD has developed a standardized international form of quality‐adjusted life year (QALY), known as the DALY, and is defined as a wasted year of healthy living as a result of premature death and years with a disability of specific severity and duration. "Premature" death is a death that occurs at an age when a person's death is not expected. The expected age at death for a person is calculated based on the predicted death for a certain age in a population standardized to the population of Japan, which has the longest life expectancy at birth in the world. The total number of DALYs for a given condition within a population is equal to the sum of years of life lost (YLLs) and years of disability of known severity and duration (YLDs). 23 , 24

The SDI is the geometric average of three indicators: (1) lag‐distributed income per capita, (2) average educational attainment of people aged 15 years and older, and (3) the total fertility rate (in people aged <25 years). 25 The SDI is the reflection of levels of social and economic conditions that can affect health outcomes in a given location. Countries and territories were categorized into five groups based on SDI values: low SDI (<0.45), low‐middle SDI (≥0.45 and <0.61), middle SDI (≥0.61 and <0.69), high‐middle SDI (≥0.69 and <0.80), and high SDI (≥0.80). 26 , 27

An age‐standardized rate (ASR) is a weighted average of the age‐specific rates per 100 000 persons, where the weights are the proportions of people within the corresponding age groups of the WHO standard population. Age‐standardized rates take into account differences in the age distribution of the population by applying the rates for each population to a standardized population. 28

Ethical considerations

The study was approved by the Ethics Committee of the Jahrom University of Medical Sciences in Iran (IR.JUMS.REC.1401.094). Informed consent was not necessary due to the use of the anonymous online dataset.

Statistical analysis

To remove the influence of the composition of different age groups within populations, incidence, prevalence, deaths, DALY and age‐standardized rates are expressed per 100 000 population. The data are reported as values with 95% confidence intervals (CI). Selected epidemiological indicators are presented separately for each classification system. To show comparative changes in incidence, prevalence, mortality, and age‐standardized rates, the relative difference (%) between years was used. The relative difference was calculated by dividing the value of the absolute difference by the value of the year of origin, which was then multiplied by 100. 29 The definition of what was used can be accessed via https://www.healthdata.org/terms-defined and https://www.healthdata.org/gbd/.

RESULTS

Morbidity of TBL cancer in Asia

Compared with global data and continents

In Asia, the number of TBL cancer incidences increased from 975 361 (95% CI: 909 679–1 037 802) in 2010 to 1 305 525 (95% CI: 1 150 171–1 455 350) in 2019, which is over a 1.34‐fold increase. In 2019 approximately 58% (1 305 525/2 259 998) of TBL cancer cases happened in Asian countries. During this period, the ASIR of TBL cancer with a 1% change, decreased from 28.08 (95% CI: 26.16–29.89) per 100 000 in 2010 to 27.82 (95% CI: 24.56–30.95) per 100 000 in 2019, while in the same time, this rate globally decreased by 5%, in America by 10%, and in Europe by 7% (Figure 1 and Table 1).

FIGURE 1.

FIGURE 1

Temporal trend of incidence, prevalence, death and DALYs age standard rates (per 100 000 population) of TBL cancer in ASIA comparison with global data and other continents from 1990 to 2019.

TABLE 1.

Comparison of the incidence, death, prevalence, and burden rates of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (both sexes).

Location Incidence Death
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)

Global

1 832 625 28.99 2 259 998 27.66 ‐0.05 1 670 745 26.70 2 042 640 25.18 ‐0.06
(1 747 456–1 909 105) (27.58–30.18) (2 067 316–2 451 832) (25.28–29.99) (‐0.13–0.03) (1 592 451–1 737 302) (25.29–27.77) (1 879 241–2 193 269) (23.16–27.01) (‐0.13–0.02)
Continents

Africa

47 663 10.39 63 899 10.46 0.01 49 125 11.07 65 621 11.15 0.01
(42 695–54 096) (9.34–11.73) (57 033–71 562) (9.4–11.63) (‐0.08–0.11) (44 347–55 559) (10–12.43) (58 557–74 115) (9.99–12.4) (‐0.08–0.1)

America

331 037 33.45 385 406 29.96 ‐0.10 282 630 28.49 331 172 25.67 ‐0.10
(316 473–339 397) (32.01–34.28) (345 604–429 508) (26.86–33.37) (‐0.19–‐0.01) (268 084–290 210) (27.07–29.23) (309 812–345 847) (24.05–26.8) (‐0.13–‐0.07)

Asia

975 361 28.08 1 305 525 27.82 ‐0.01 906 650 26.66 1 190 516 25.76 ‐0.03
(909 679–1 037 802) (26.16–29.89) (1 150 171–1 455 350) (24.56–30.95) (‐0.13–0.12) (846 561–964 850) (24.77–28.33) (1 052 836–1 330 529) (22.79–28.72) (‐0.15–0.09)
Europe 476 813 36.07 503 130 33.37 ‐0.07 430 658 32.16 453 373 29.55 ‐0.08
(459 978–486 467) (34.9–36.76) (455 166–552 462) (30.25–36.73) (‐0.16–0.02) (413 701–440 000) (31.01–32.82) (426 326–476 093) (27.88–31.01) (‐0.12–‐0.04)
Countries by geographical location

Central Asia

11 934 20.23 14 342 18.91 ‐0.07 11 820 20.47 13 990 19.04 ‐0.07
(11 487–12 356) (19.45–20.94) (12 983–15 870) (17.14–20.76) (‐0.15–0.03) (11 373–12 240) (19.68–21.2) (12 661–15 452) (17.29–20.86) (‐0.15–0.02)

East Asia

628 151 41.17 854 582 41.31 0.00 594 187 39.99 778 387 38.38 ‐0.04
(575 530–685 242) (37.73–44.79) (721 022–1 002 044) (35.03–48.11) (‐0.17–0.19) (541 920–645 351) (36.53–43.35) (658 108–907 254) (32.72–44.57) (‐0.19–0.14)

High‐income Asia Pacific

131 569 34.89 150 900 31.57 ‐0.10 95 867 24.78 110 970 22.17 ‐0.11
(119 593–138 366) (32.07–36.51) (126 657–173 088) (26.96–36.26) (‐0.2–0.02) (85 867–101 050) (22.5–25.98) (96 055–119 283) (19.73–23.56) (‐0.13–‐0.08)

North Africa and Middle East

52 191 16.66 71 681 16.83 0.01 53 176 17.44 72 510 17.55 0.01
(48 178–56 416) (15.33–17.98) (63 424–81 049) (14.91–19.02) (‐0.1–0.14) (48 971–57 366) (16.03–18.79) (64 112–81 925) (15.56–19.82) (‐0.1–0.13)

South Asia

80 950 7.84 117 195 8.36 0.07 82 457 8.25 119 644 8.75 0.06
(74 897–86 782) (7.24–8.41) (100 085–133 943) (7.14–9.52) (‐0.09–0.22) (76 287–88 125) (7.61–8.85) (101 195–137 368) (7.44–10.05) (‐0.09–0.21)

Southeast Asia

96 767 21.48 132 529 21.99 0.02 98 814 22.62 134 566 23.00 0.02
(87 575–106 118) (19.42–23.5) (110 981–153 557) (18.43–25.41) (‐0.1–0.16) (90 026–107 961) (20.57–24.72) (112 781–155 885) (19.25–26.63) (‐0.1–0.14)
Location Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)

Global

2 557 647 39.76 3 212 307 38.84 ‐0.02 38 816 797 595.08 45 857 963 551.58 ‐0.07
(2 451 258–2 653 706) (38.02–41.26) (2 937 037–3 488 346) (35.49–42.16) (‐0.1–0.05) (37 161 595–40 409 438) (569.46–619.44) (42 297 425–49 339 876) (508.97–593.12) (‐0.15–0)
Continents

Africa

48 619 9.97 66 194 10.14 0.02 1 297 006 258.89 1 724 110 257.28 ‐0.01
(43 488–55 370) (8.93–11.32) (58 602–74 477) (9.06–11.34) (‐0.07–0.12) (1 157 918–1 478 946) (232.57–293.8) (1 518 047–1 970 898) (228.41–292.12) (‐0.1–0.1)

America

532 344 53.91 609 633 47.55 ‐0.12 6 111 998 616.56 6 982 073 548.34 ‐0.11
(512 813–546 055) (51.96–55.3) (542 652–684 277) (42.33–53.36) (‐0.22–‐0.01) (5 919 808–6 223 069) (597.39–627.78) (6 655 043–7 266 920) (522.67–570.79) (‐0.14–‐0.08)

Asia

1 308 776 36.35 1 820 539 37.81 0.04 21 516 974 579.16 27 120 537 553.68 ‐0.04
(1 225 459–1 392 332) (34.01–38.67) (1 605 530–2 034 496) (33.46–42.14) (‐0.09–0.17) (20 162 682–22 913 727) (543.52–616.66) (23 951 875–30 414 194) (488.57–619.78) (‐0.16–0.09)
Europe 665 767 51.86 713 441 49.08 ‐0.05 9 853 259 776.31 9 988 808 698.29 ‐0.10
(644 824–680 187) (50.39–52.93) (642 607–790 401) (44.21–54.34) (‐0.15–0.05) (9 590 547–10 021 168) (758.05–789.01) (9 442 180–10 489 803) (660.78–732.91) (‐0.14–‐0.06)
Countries by geographical location

Central Asia

13 055 21.17 16 240 20.13 ‐0.05 327 135 520.66 387 448 473.70 ‐0.09
(12 554–13 538) (20.33–21.93) (14 651–18 053) (18.23–22.19) (‐0.14–0.05) (315 044–338 748) (500.81–539.35) (349 153–429 746) (428.64–523.63) (‐0.18–0.01)

East Asia

783 584 49.06 1 163 481 54.46 0.11 14 113 044 872.01 17 614 063 825.81 ‐0.05
(715 846–857 024) (44.9–53.51) (976 059–1 369 145) (45.82–63.97) (‐0.09–0.33) (12 887 293–15 406 968) (797.95–948.78) (14 810 292–20 721 521) (696.85–969.46) (‐0.21–0.14)

High‐income Asia Pacific

288 182 80.42 326 643 74.32 ‐0.08 1 745 570 494.73 1 830 128 427.39 ‐0.14
(267 010–304 566) (75.25–84.6) (276 230–376 769) (63.96–85.75) (‐0.19–0.06) (1 622 311–1 810 575) (464.58–510.51) (1 654 973–1 933 641) (395.68–448.33) (‐0.16–‐0.11)

North Africa and Middle East

55 161 16.74 77 317 17.17 0.03 1 389 718 412.53 1 870 025 406.65 ‐0.01
(50 926–59 688) (15.46–18.13) (68 022–87 610) (15.15–19.45) (‐0.09–0.16) (1 283 476–1 507 225) (380.92–447.32) (1 648 815–2 118 436) (359.1–459.46) (‐0.13–0.11)

South Asia

84 029 7.72 121 387 8.31 0.08 2 207 925 198.52 3 089 930 208.53 0.05
(77 729–90 153) (7.13–8.27) (103 595–139 072) (7.1–9.5) (‐0.08–0.24) (2 042 685–2 363 198) (183.68–212.2) (2 617 375–3 550 873) (176.65–239.62) (‐0.11–0.21)

Southeast Asia

102 121 21.45 141 713 22.31 0.04 2 580 293 530.60 3 429 720 532.93 0.00
(92 437–112 157) (19.46–23.5) (118 238–165 160) (18.65–25.86) (‐0.09–0.18) (2 343 315–2 826 856) (483.12–580.93) (2 859 905–3 965 337) (445.89–615.84) (‐0.12–0.13)

Abbreviations: CI, confidence interval; TBL, tracheal, bronchial and lung.

In Asian men, the number of TBL cancer incidences increased from 695 259 (95% CI: 643 022–750 702) in 2010 to 906 593 (95% CI: 771 042–1 049 246) in 2019, which is over a 1.3‐fold increase. In 2019 approximately 69.4% of Asia TBL cancer new cases, occurred in Asian men which included 59.5% (906 593/1 522 773) of global male TBL cancer incidence cases. During this period, the ASIR of TBL cancer with a 3% change, decreased from 42.54 (95% CI: 39.28–45.84) per 100 000 in 2010 to 41.16 (95% CI: 35.32–47.32) per 100 000 in 2019, while in the same time, this rate globally decreased by 7%, in America and Europe by 12% (Table 2).

TABLE 2.

Comparison of the incidence, death, prevalence and burden rates of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (males).

Location Incidence Death
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Global 1 266 190 43.69 1 522 773 40.44 ‐0.07 1 164 258 40.94 1 386 094 37.38 ‐0.09
(1 202 565–1 326 841) (41.45–45.77) (1 373 842–1 676 681) (36.55–44.42) (‐0.17–0.02) (1 108 350–1 215 596) (38.85–42.68) (1 260 237–1 513 800) (34.09–40.74) (‐0.17–0)
Continents

Africa

36 549 16.38 47 159 16.09 ‐0.02 37 728 17.53 48 544 17.21 ‐0.02
(32 136–42 571) (14.45–18.97) (41 687–53 671) (14.27–18.13) (‐0.12–0.1) (33 410–43 751) (15.57–20.2) (42 915–55 500) (15.31–19.47) (‐0.11–0.09)

America

186 025 41.78 214 269 36.70 ‐0.12 162 602 36.77 188 270 32.43 ‐0.12
(179 186–189 993) (40.16–42.72) (186 646–245 610) (31.99–42.07) (‐0.23–0) (156 145–166 234) (35.23–37.65) (178 831–195 807) (30.74–33.75) (‐0.14–‐0.09)

Asia

695 259 42.54 906 593 41.16 ‐0.03 646 099 40.66 825 738 38.30 ‐0.06
(643 022–750 702) (39.28–45.84) (771 042–1 049 246) (35.32–47.32) (‐0.18–0.12) (599 147–694 710) (37.75–43.57) (706 207–949 796) (33–43.79) (‐0.19–0.09)
Europe 347 179 60.89 353 424 53.32 ‐0.12 316 705 55.64 322 275 48.46 ‐0.13
(337 249–353 973) (59.11–62.1) (320 472–389 686) (48.36–58.75) (‐0.21–‐0.03) (306 915–322 902) (53.81–56.78) (303 139–339 418) (45.56–51.06) (‐0.17–‐0.09)
Countries by geographical location

Central Asia

9537 37.59 11 253 34.44 ‐0.08 9420 38.30 10 955 34.98 ‐0.09
(9122–9950) (35.97–39.22) (9979–12 553) (30.72–38.1) (‐0.17–0.02) (9018–9823) (36.71–39.94) (9718–12 201) (31.18–38.66) (‐0.18–0.01)

East Asia

442 614 61.68 590 047 61.06 ‐0.01 418 526 60.80 536 789 57.50 ‐0.05
(394 667–493 908) (55.3–68.47) (467 100–722 744) (48.89–73.86) (‐0.22–0.24) (376 929–464 328) (55.06–66.96) (427 357–661 038) (46.25–69.74) (‐0.25–0.17)

High‐income Asia Pacific

95 187 58.88 105 806 50.61 ‐0.14 68 875 42.74 76 809 36.15 ‐0.15
(88 757–99 228) (54.81–61.39) (89 324–125 121) (42.87–59.61) (‐0.26–0.01) (63 689–71 709) (39.41–44.55) (69 027–81 528) (32.76–38.31) (‐0.18–‐0.13)

North Africa and Middle East

42 203 26.63 55 843 25.77 ‐0.03 43 261 28.02 57 114 27.16 ‐0.03
(38 782–45 960) (24.42–28.91) (49 149–63 493) (22.74–29.16) (‐0.15–0.1) (39 698–46 972) (25.64–30.39) (50 323–64 674) (24.02–30.62) (‐0.14–0.1)
South Asia 63 332 12.38 85 412 12.42 0.00 64 539 13.05 87 160 13.03 0.00
(57 745–69 047) (11.25–13.47) (69 746–101 658) (10.19–14.74) (‐0.18–0.2) (58 846–70 169) (11.88–14.19) (71 240–102 821) (10.68–15.32) (‐0.18–0.18)

Southeast Asia

67 604 32.97 91 221 33.20 0.01 68 978 34.96 92 416 34.97 0.00
(62 062–73 776) (30.32–35.86) (76 900–106 089) (28.16–38.38) (‐0.13–0.16) (63 777–74 766) (32.35–37.91) (78 453–106 933) (29.78–40.37) (‐0.13–0.14)
Location Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Global 1 716 379 57.22 2 109 409 54.52 ‐0.05 27 443 591 891.68 31 582 258 802.86 ‐0.10
(1 639 042–1 795 082) (54.61–59.84) (1 895 836–2 337 805) (49.05–60.18) (‐0.14–0.05) (26 238 635–28 695 342) (851.85–931.53) (28 622 120–34 681 701) (727.6–879.76) (‐0.19–0)
Continents

Africa

37 211 15.64 48 599 15.49 ‐0.01 996 182 407.65 1 273 661 395.57 ‐0.03
(32 606–43 427) (13.77–18.18) (42 835–55 456) (13.7–17.58) (‐0.11–0.11) (874 751–1 168 008) (360.63–474.74) (1 115 235–1 475 387) (348.98–453.39) (‐0.13–0.09)

America

280 546 62.13 318 385 53.95 ‐0.13 3 578 682 782.87 4 019 140 681.21 ‐0.13
(271 942–287 853) (60.11–63.8) (274 446–370 922) (46.52–62.82) (‐0.25–0.01) (3 486 125–3 640 976) (761.01–796.82) (3 866 967–4 175 479) (654.95–707.55) (‐0.16–‐0.1)

Asia

928 147 54.01 1 257 715 54.94 0.02 15 471 795 862.61 19 032 930 806.43 ‐0.07
(861 104–1 000 537) (50.08–58.12) (1 069 513–1 462 350) (46.96–63.32) (‐0.13–0.18) (14 340 748–16 696 371) (800.85–929.03) (16 188 395–21 991 610) (688.15–928.33) (‐0.21–0.1)
Europe 469 031 82.35 483 071 73.66 ‐0.11 7 371 434 1296.88 7 228 445 1112.90 ‐0.14
(456 266–479 691) (80.06–84.24) (434 425–538 524) (66.24–82.02) (‐0.2–‐0.01) (7 210 498–7 495 109) (1268.24–1318.81) (6 786 085–7 659 648) (1044.81–1178.58) (‐0.19–‐0.09)
Countries by geographical location

Central Asia

10 445 38.69 12 747 35.93 ‐0.07 262 480 950.54 305 280 845.18 ‐0.11
(9966–10 916) (36.98–40.34) (11 269–14 251) (31.94–39.9) (‐0.17–0.03) (250 744–274 008) (909.87–992.11) (269 545–342 706) (750.29–941.04) (‐0.2–‐0.01)

East Asia

549 320 71.26 798 517 78.03 0.09 10 022 616 1276.56 12 285 616 1195.54 ‐0.06
(489 021–614 703) (63.72–79.36) (623 900–988 417) (61.43–95.66) (‐0.14–0.39) (8 962 494–11 190 274) (1148.68–1419.36) (970 2712–15 269 024) (949.99–1478.03) (‐0.27–0.18)

High‐income Asia Pacific

207 771 129.02 229 777 114.22 ‐0.11 1 293 998 813.32 1 318 234 670.81 ‐0.18
(194 401–219 959) (121.06–136.58) (191 569–273 165) (95.69–135.71) (‐0.26–0.06) (1 225 352–1 335 843) (770.31–839.29) (1 219 937–1 388 347) (624.48–704.7) (‐0.21–‐0.15)

North Africa and Middle East

43 906 26.37 58 612 25.59 ‐0.03 1 129 551 663.37 1 471 977 629.27 ‐0.05
(40 334–47 853) (24.21–28.71) (51 424–66 749) (22.48–29.12) (‐0.15–0.11) (1 037 014–1 231 394) (609.93–724.26) (1 292 740–1 675 771) (554.11–713.7) (‐0.17–0.09)
South Asia 65 683 12.12 88 383 12.28 0.01 1 720 712 310.76 2 242 983 306.69 ‐0.01
(59 942–71 764) (11.06–13.21) (72 063–105 442) (10.04–14.62) (‐0.17–0.22) (1 574 121–1 878 619) (283.66–338.27) (1 835 005–2 652 810) (251.04–361.99) (‐0.2–0.18)

Southeast Asia

71 517 32.53 97 906 33.25 0.02 1 810 079 804.60 2 378 099 795.16 ‐0.01
(65 595–78 128) (29.89–35.41) (81 821–114 685) (27.99–38.75) (‐0.13–0.19) (1 666 282–1 968 106) (742.9–872.82) (1 995 969–2 766 343) (672.65–921.59) (‐0.15–0.14)

Abbreviations: CI, confidence interval; TBL, tracheal, bronchial and lung.

In Asian women, the number of TBL cancer incidences increased from 280 101 (95% CI: 256 006–302 969) in 2010 to 398 932 (95% CI: 339 662–464 457) in 2019, which is over a 1.42‐fold increase. In 2019 approximately 30.6% of Asia TBL cancer new cases, occurred in Asian women which included 54.1% (398 932/737 225) of global female TBL cancer incidence cases. During this period, the ASIR of TBL cancer with a 5% change, increased from 15.48 (95% CI: 14.07–16.76) per 100 000 in 2010 to 16.21 (95% CI: 13.74–18.85) per 100 000 in 2019, while in the same time, this rate globally increased by 1%, in Africa by 12%, and in Europe by 3%, and in American countries decreased by 8% (Table 3).

TABLE 3.

Comparison of the incidence, death, prevalence and burden rates of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (females).

Location Incidence Death
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Global 566 435 16.68 737 225 16.84 0.01 506 487 14.97 656 546 14.99 0.00
(531 214–594 093) (15.62–17.5) (658 040–813 972) (15.03–18.59) (‐0.08–0.1) (472 370–533 707) (13.92–15.76) (590 247–718 975) (13.48–16.41) (‐0.08–0.09)
Continents
Africa 11 114 4.73 16 740 5.29 0.12 11 397 5.04 17 076 5.62 0.12
(10 146–12 213) (4.32–5.18) (14 748–18 781) (4.68–5.89) (0–0.22) (10 387–12 508) (4.58–5.52) (14 976–19 279) (4.97–6.28) (0–0.23)
America 145 012 26.71 171 137 24.45 ‐0.08 120 028 21.83 142 902 20.17 ‐0.08
(136 453–149 964) (25.31–27.57) (146 572–197 699) (20.96–28.29) (‐0.21–0.05) (111 881–124 413) (20.5–22.58) (130 834–152 666) (18.57–21.51) (‐0.12–‐0.03)
Asia 280 101 15.48 398 932 16.21 0.05 260 550 14.67 364 778 14.98 0.02
(256 006–302 969) (14.07–16.76) (339 662–464 457) (13.74–18.85) (‐0.1–0.22) (238 233–282 526) (13.35–15.92) (312 089–421 085) (12.81–17.27) (‐0.12–0.17)
Europe 129 633 17.28 149 706 17.72 0.03 113 953 14.74 131 099 14.98 0.02
(122 363–133 692) (16.47–17.75) (133 119–167 334) (15.85–19.87) (‐0.07–0.14) (106 426–117 617) (13.94–15.15) (120 753–138 421) (13.94–15.79) (‐0.02–0.06)
Countries by geographical location
Central Asia 2397 7.22 3089 7.45 0.03 2400 7.38 3035 7.54 0.02
(2310–2491) (6.94–7.52) (2767–3451) (6.7–8.27) (‐0.07–0.14) (2307–2496) (7.08–7.67) (2724–3375) (6.81–8.35) (‐0.08–0.13)
East Asia 185 537 23.56 264 535 24.55 0.04 175 661 22.78 241 598 22.70 0.00
(165 513–205 184) (21.05–26.05) (213 472–322 034) (19.85–29.85) (‐0.16–0.3) (156 904–194 255) (20.41–25.12) (196 028–289 422) (18.46–27.15) (‐0.2–0.22)
High‐income Asia Pacific 36 382 16.86 45 094 16.45 ‐0.02 26 992 11.76 34 161 11.37 ‐0.03
(30 613–39 687) (14.74–18.09) (35 652–53 403) (13.64–19.2) (‐0.15–0.12) (22 018–29 634) (10.03–12.69) (27 113–38 231) (9.6–12.41) (‐0.07–0)
North Africa and Middle East 9987 6.46 15 838 7.62 0.18 9915 6.65 15 396 7.68 0.15
(9196–10 762) (5.93–6.97) (13 642–18 196) (6.56–8.74) (0.03–0.32) (9104–10 671) (6.08–7.16) (13 258–17 676) (6.59–8.77) (0.01–0.29)
South Asia 17 618 3.40 31 783 4.47 0.32 17 918 3.58 32 485 4.69 0.31
(15 685–19 518) (3.01–3.8) (25 999–38 175) (3.67–5.37) (0.06–0.61) (15 757–19 848) (3.12–4) (26 638–39 104) (3.86–5.64) (0.05–0.6)
Southeast Asia 29 163 11.99 41 308 12.78 0.07 29 836 12.61 42 151 13.36 0.06
(24 280–34 189) (10.03–14) (316 31–51 823) (9.8–15.93) (‐0.08–0.22) (24 900–34 975) (10.55–14.7) (32 050–52 566) (10.19–16.57) (‐0.09–0.21)
Location Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Global 841 268 24.67 1 102 899 25.22 0.02 11 373 206 331.74 14 275 706 327.57 ‐0.01
(796 537–877 004) (23.35–25.72) (989 626–1 214 657) (22.65–27.78) (‐0.07–0.12) (10 770 628–11 958 278) (314.19–348.96) (13 000 079–15 704 795) (298.53–360.45) (‐0.1–0.08)
Continents
Africa 11 408 4.54 17 596 5.17 0.14 300 825 116.06 450 450 128.37 0.11
(10 366–12 602) (4.15–4.99) (15 351–19 862) (4.58–5.79) (0.01–0.25) (271 961–331 332) (105.52–127.2) (390 478–514 074) (111.98–145.41) (‐0.02–0.23)
America 251 798 47.23 291 248 42.31 ‐0.10 2 533 317 474.98 2 962 933 434.89 ‐0.08
(240 507–260 562) (45.24–48.84) (246 138–341 703) (35.74–49.7) (‐0.24–0.05) (2 428 813–2 599 251) (456.25–486.94) (2 776 613–3 144 654) (408.17–460.97) (‐0.13–‐0.03)
Europe 380 630 20.43 562 824 22.49 0.10 6 045 179 316.95 8 087 606 321.18 0.01
(349 763–411 327) (18.67–22.08) (480 164–653 889) (19.21–26.12) (‐0.06–0.28) (5 551 988–6 575 776) (290.95–344.55) (6 962 536–9 358 865) (276.65–371.34) (‐0.14–0.18)
Asia 196 736 27.82 230 370 29.17 0.05 2 481 824 355.87 2 760 363 354.87 0.00
(187 564–203 168) (26.7–28.66) (205 639–257 874) (25.99–32.68) (‐0.06–0.18) (2 377 313–2 540 942) (343.94–363.58) (2 583 575–2 917 832) (334.93–374.7) (‐0.05–0.05)
Countries by geographical location
Central Asia 2611 7.54 3492 7.98 0.06 64 655 183.44 82 168 185.27 0.01
(2518–2720) (7.28–7.86) (3111–3917) (7.15–8.91) (‐0.05–0.18) (62 448–67 272) (176.8–191.03) (73 024–92 405) (165.25–207.53) (‐0.1–0.13)
East Asia 234 264 28.75 364 964 33.32 0.16 4 090 428 497.71 5 328 447 489.73 ‐0.02
(208 597–260 494) (25.64–31.99) (293 511–447 082) (26.81–40.82) (‐0.08–0.45) (3 645 348–4 549 759) (442.89–552.1) (4 314 330–6 510 671) (396.14–597.18) (‐0.23–0.22)
High‐income Asia Pacific 80 411 41.17 96 866 40.86 ‐0.01 451 572 235.42 511 894 219.77 ‐0.07
(70 235–87 650) (37.37–44.11) (79 104–114 755) (34.13–48.03) (‐0.15–0.16) (395 398–481 572) (213.57–247.32) (437 678–555 713) (197.35–234.68) (‐0.1–‐0.03)
North Africa and Middle East 11 255 6.83 18 705 8.43 0.23 260 168 153.63 398 048 174.91 0.14
(10 374–12 083) (6.29–7.34) (16 152–21 456) (7.27–9.65) (0.07–0.39) (240 453–279 924) (141.58–165.39) (343 405–459 210) (151.1–201.59) (‐0.01–0.28)
South Asia 18 346 3.35 33 004 4.46 0.33 487 213 86.82 846 947 112.79 0.30
(16 385–20 206) (2.98–3.71) (26 751–39 840) (3.64–5.38) (0.07–0.64) (435 355–537 136) (77.13–95.86) (692 032–1 029 549) (92.18–136.92) (0.04–0.6)
Southeast Asia 30 604 12.01 43 807 13.01 0.08 770 214 295.65 1 051 621 308.47 0.04
(25 450–35 989) (10.04–14.06) (33 416–55 120) (9.98–16.28) (‐0.07–0.25) (633 511–914 063) (243.82–348.23) (796 523–1 324 390) (233.06–387.26) (‐0.11–0.2)

Abbreviations: CI, confidence interval; TBL, tracheal, bronchial and lung.

Age distribution

In 2019, age‐specific incidence cases of TBL cancer were generally peaking at 65–74 years, 65–69 years in males, and 70–74 years in females. In all age groups, the incidence cases of TBL cancer in males was higher, except in ages above 90 years which in females was higher (Figure 2).

FIGURE 2.

FIGURE 2

Age specific incidence cases of TBL cancer among sexes in Asia, 2019.

Within Asian regions

In 2019, the highest ASIR of TBL was observed in East Asian countries (41.31 [95% CI: 35.03–48.11]); without any changes compared with 2010. While the Central Asia and high‐income Asia Pacific countries experienced a decreasing trend of 10% and 7%, respectively; the South Asian countries experienced the highest increasing trend from 2010 to 2019 (by 7%) (Figure 3).

FIGURE 3.

FIGURE 3

Temporal trend of incidence, prevalence, death and DALYs age standard rates (per 100 000 population) of TBL cancer in Asian regions from 1990 to 2019.

In men, the highest ASIR of TBL was observed in East Asian countries (61.06 [95% CI: 48.89–73.86]); with a 1% decrease compared with 2010. While the Central Asia and high‐income Asia Pacific countries experienced a decreasing trend of 8% and 14%, respectively; the Southeast Asia countries experienced an increasing trend from 2010 to 2019 by 1%.

In women, the highest ASIR of TBL was observed in East Asian countries (24.55 [95% CI: 19.85–29.85]) in 2019, these countries and other countries experienced an increasing trend from 2010 to 2019 except high‐income Asia Pacific countries that experienced a decreasing trend by 2%. South Asia countries experienced the highest increasing trend from 2010 to 2019 (by 32%).

Among high SDI Asian countries, Brunei Darussalam (46.15) and the Republic of Korea (35.61) had the highest ASIR of TBL, and Saudi Arabia (8.77) had the lowest rate.

Based on SDI

Among high SDI Asian countries, Brunei Darussalam (45.16) and the Republic of Korea (35.61) had the highest ASIR of TBL, and Saudi Arabia (8.77) had the lowest rate. Among high‐middle SDI Asian countries, Turkey (33.08) and Georgia (31.14) had the highest ASIR of TBL, and Sri Lanka (9.71) had the lowest rate. Among middle SDI Asian countries, China (41.71) and Armenia (33.81) had the highest ASIR of TBL, and Turkmenistan (9.90) had the lowest rate. Among low‐middle SDI Asian countries, Mongolia (31.19) and the Democratic People's Republic of Korea (27.87) had the highest ASIR of TBL, and Bangladesh (7.43) had the lowest rate. Among low SDI Asian countries, Pakistan (16.43) had the highest ASIR of TBL, and Nepal (8.03) had the lowest rate. Further details are presented in Table 4.

TABLE 4.

Incidence distribution of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Both Male Female
2010 2019 % change 2010‐2010 2010 2019 % change 2010‐2019 2010 2019 % change 2010‐2019
Location SDI 2019 lower Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
High SDI
Brunei Darussalam 0.823 75 46.27 116 46.15 0.00 42 60.33 63 61.02 0.01 33 36.25 53 37.94 0.05
(69–82) (42.48–50.29) (102–130) (40.91–51.83) (‐0.13–0.13) (38–47) (53.39–67.93) (52–75) (51.36–71.21) (‐0.16–0.21) (29–37) (32.03–40.41) (44–63) (32.3–44.03) (‐0.13–0.25)
Cyprus 0.841 402 28.10 514 26.03 ‐0.07 314 48.19 398 42.31 ‐0.12 88 11.61 116 11.39 ‐0.02
(374–430) (26.17–30) (444–592) (22.56–30.01) (‐0.21–0.08) (289–339) (44.52–51.86) (330–469) (35.14–49.85) (‐0.28–0.05) (79–98) (10.48–12.77) (95–138) (9.37–13.59) (‐0.2–0.17)
Israel 0.803 2177 25.06 2670 23.37 ‐0.07 1454 37.13 1752 33.44 ‐0.10 722 14.94 918 14.64 ‐0.02
(2059–2270) (23.75–26.11) (2088–3391) (18.1–29.71) (‐0.27–0.18) (1379–1533) (35.22–39.1) (1347–2241) (25.75–42.7) (‐0.31–0.15) (664–771) (13.82–15.89) (724–1168) (11.54–18.64) (‐0.22–0.24)
Japan 0.87 107 228 34.48 116 798 30.66 ‐0.11 77 692 57.88 81 717 49.05 ‐0.15 29 535 16.57 35 081 15.94 ‐0.04
(96 325–113 274) (31.52–36.12) (95 776–136 541) (25.55–36) (‐0.24–0.04) (71 790–81 155) (53.74–60.37) (66 731–99 572) (40–59.9) (‐0.3–0.03) (24 210–32 466) (14.34–17.85) (26 628–42 644) (12.55–19.49) (‐0.2–0.16)
Kuwait 0.851 129 10.02 225 10.10 ‐0.18 98 12.48 173 13.28 0.06 31 5.92 53 5.18 ‐0.12
(119–137) (9.15–10.72) (185–272) (8.19–12.19) (‐0.3–‐0.04) (90–105) (11.35–13.45) (133–216) (10.29–16.6) (‐0.17–0.34) (28–34) (5.24–6.53) (41–66) (4.08–6.47) (‐0.3–0.09)
Qatar 0.83 69 21.90 125 18.78 0.02 58 26.31 103 21.19 ‐0.19 11 12.28 21 11.80 ‐0.04
(55–85) (18.02–26.44) (89–174) (14.38–23.88) (‐0.19–0.27) (45–73) (20.85–32.57) (71–149) (15.97–27.58) (‐0.41–0.09) (9–13) (9.85–14.95) (16–27) (9.21–14.72) (‐0.23–0.17)
Republic of Korea 0.878 22 698 36.90 31 825 35.61 ‐0.14 16 431 65.28 22 655 59.14 ‐0.09 6266 17.78 9170 18.25 0.03
(21 256–24 229) (34.36–39.47) (26 456–37 538) (29.58–41.94) (‐0.35–0.11) (15 413–17 712) (60.97–70.45) (18 637–27 109) (48.64–70.35) (‐0.25–0.08) (5647–6772) (15.98–19.21) (7492–10 916) (14.97–21.76) (‐0.14–0.21)
Saudi Arabia 0.805 1032 9.13 1545 8.77 ‐0.04 771 12.14 1115 10.94 ‐0.10 261 5.08 429 5.46 0.07
(909–1197) (8.21–10.31) (1187–1900) (6.98–10.62) (‐0.19–0.14) (680–897) (10.9–14.02) (841–1392) (8.54–13.69) (‐0.29–0.11) (225–299) (4.44–5.78) (321–551) (4.16–6.88) (‐0.17–0.35)
Singapore 0.861 1568 33.19 2162 28.39 ‐0.04 1021 48.41 1371 38.69 ‐0.20 547 21.28 790 19.73 ‐0.07
(1463–1657) (30.81–35.1) (1724–2713) (22.71–35.43) (‐0.22–0.16) (951–1085) (44.94–51.53) (1081–1724) (30.75–48.3) (‐0.37–0) (498–592) (19.27–23.06) (627–991) (15.65–24.76) (‐0.25–0.15)
Taiwan (Province of China) 0.868 10 295 34.33 12 618 31.88 ‐0.07 6690 46.05 7802 42.62 ‐0.07 3605 23.35 4815 22.78 ‐0.02
(9689–10 735) (32.27–35.75) (9963–16 206) (25.21–40.93) (‐0.27–0.18) (6311–6979) (43.42–48.07) (6140–9885) (33.46–54.21) (‐0.27–0.19) (3337–3813) (21.55–24.72) (3751–6185) (17.78–29.35) (‐0.23–0.25)
United Arab Emirates 0.88 227 22.85 542 18.62 ‐0.18 176 25.31 434 21.52 ‐0.15 51 18.43 108 12.79 ‐0.31
(181–274) (18.93–26.98) (393–721) (13.54–25.75) (‐0.37–0.06) (138–216) (20.35–30.9) (310–593) (15.82–29.85) (‐0.33–0.09) (40–63) (14.8–22.63) (72–145) (7.5–19.26) (‐0.58–0.1)
High‐middle SDI
Bahrain 0.751 85 24.23 141 19.84 ‐0.18 62 34.52 104 26.50 ‐0.23 23 13.99 37 12.46 ‐0.11
(75–95) (21.4–27.15) (107–186) (15.2–25.09) (‐0.36–0.02) (53–71) (29.94–39.4) (75–142) (19.94–34.33) (‐0.42–0) (20–26) (12.09–16.15) (29–45) (9.96–15.05) (‐0.28–0.07)
Georgia 0.702 1662 29.30 1784 31.14 0.06 1400 58.14 1515 62.13 0.07 261 7.81 269 8.03 0.03
(1515–1810) (26.6–31.96) (1487–2108) (25.89–36.87) (‐0.13–0.29) (1252–1545) (52.05–64.25) (1251–1796) (51.46–73.5) (‐0.13–0.3) (235–290) (7.01–8.66) (224–322) (6.65–9.7) (‐0.18–0.26)
Jordan 0.731 485 15.10 914 14.34 ‐0.05 383 23.14 697 20.90 ‐0.10 102 6.42 218 7.19 0.12
(431–543) (13.47–16.94) (748–1110) (11.86–17.36) (‐0.23–0.14) (336–437) (20.32–26.46) (537–882) (16.3–26.2) (‐0.3–0.14) (87–117) (5.51–7.41) (171–277) (5.69–9.03) (‐0.11–0.4)
Kazakhstan 0.723 3740 25.91 3829 21.36 ‐0.14 3062 52.86 3047 41.77 ‐0.21 678 8.02 782 7.67 ‐0.04
(3558–3945) (24.65–27.24) (3259–4406) (18.36–24.44) (‐0.31–0.06) (2885–3267) (49.82–56.14) (2577–3559) (35.53–48.48) (‐0.33–‐0.08) (641–718) (7.58–8.48) (656–915) (6.46–8.97) (‐0.21–0.13)
Lebanon 0.708 1183 27.80 1421 27.29 ‐0.07 841 41.03 914 38.92 ‐0.05 342 15.58 507 17.75 0.14
(1016–1518) (23.82–35.74) (1168–1868) (22.42–35.83) (‐0.18–0.06) (699–1095) (34.1–53.77) (729–1203) (30.94–51.44) (‐0.2–0.13) (284–441) (12.95–20.1) (375–703) (13.08–24.52) (‐0.14–0.39)
Malaysia 0.737 3915 21.33 5165 19.78 0.03 2743 30.05 3642 28.00 ‐0.07 1173 12.86 1523 11.70 ‐0.09
(3573–4318) (19.34–23.57) (3997–6561) (15.37–25.12) (‐0.16–0.25) (2494–3026) (27.12–33.41) (2793–4631) (21.62–35.55) (‐0.28–0.18) (1058–1301) (11.53–14.41) (1163–1934) (8.98–14.81) (‐0.29–0.14)
Oman 0.783 119 11.97 147 9.86 0.14 88 16.17 102 12.86 ‐0.21 31 6.96 45 6.72 ‐0.03
(109–131) (10.89–13.07) (117–192) (8.16–11.94) (‐0.1–0.41) (79–98) (14.56–17.97) (76–145) (10.25–16.55) (‐0.37–0.04) (27–36) (6.02–7.98) (33–54) (5.08–8.06) (‐0.26–0.17)
Sri Lanka 0.69 1963 10.10 2507 9.71 ‐0.04 1446 16.37 1731 15.00 ‐0.08 517 4.97 775 5.51 0.11
(1848–2087) (9.5–10.73) (1822–3414) (7.08–13.11) (‐0.29–0.3) (1338–1549) (15.11–17.54) (1203–2446) (10.53–20.91) (‐0.34–0.29) (472–567) (4.56–5.46) (571–1026) (4.06–7.27) (‐0.19–0.44)
Turkey 0.748 23 266 34.31 29 511 33.08 ‐0.04 19 710 61.72 24 326 57.70 ‐0.07 3556 9.96 5185 11.13 0.12
(20 540–26 279) (30.29–38.64) (23 370–36 799) (26.25–41.11) (‐0.25–0.25) (17 304–22 401) (54.28–70.08) (19 210–30 440) (45.57–72.04) (‐0.28–0.22) (3128–4031) (8.77–11.28) (4127–6459) (8.87–13.83) (‐0.13–0.43)
Middle SDI
Armenia 0.689 1316 35.13 1346 31.80 ‐0.09 1085 67.75 1105 60.67 ‐0.10 231 10.73 241 10.22 ‐0.05
(1260–1376) (33.69–36.69) (1130–1596) (26.74–37.68) (‐0.24–0.07) (1035–1141) (64.76–71.21) (925–1317) (50.99–72.07) (‐0.25–0.06) (216–246) (10.07–11.45) (201–285) (8.49–12.07) (‐0.22–0.14)
Azerbaijan 0.683 1748 23.41 2375 23.47 0.00 1404 41.30 1922 41.36 0.00 344 8.69 454 8.92 0.03
(1484–1986) (19.89–26.53) (1746–3042) (17.37–29.48) (‐0.19–0.23) (1145–1636) (33.91–48.1) (1298–2561) (28.35–54.1) (‐0.23–0.28) (298–401) (7.43–10.1) (350–577) (6.97–11.37) (‐0.18–0.29)
China 0.686 610 140 41.51 832 922 41.71 0.00 430 691 62.27 576 186 61.74 ‐0.01 179 449 23.73 256 736 24.76 0.04
(557 957–666 933) (38–45.26) (700 293–981 632) (35.22–48.8) (‐0.17–0.2) (383 493–481 118) (55.7–69.25) (451 396–709 265) (48.93–75.2) (‐0.22–0.25) (159 280–199 243) (21.12–26.3) (205 684–314 159) (19.89–30.26) (‐0.17–0.3)
Indonesia 0.66 34 906 21.37 48 199 22.87 0.07 24 046 31.51 32 897 33.24 0.05 10 860 12.55 15 302 13.85 0.10
(27 783–40 662) (17.15–24.9) (35 266–59 309) (16.78–28.04) (‐0.12–0.28) (19 581–29 530) (26.13–37.98) (24 544–43 307) (25.13–42.84) (‐0.18–0.33) (6739–15 321) (7.83–17.48) (8548–22 850) (7.74–20.59) (‐0.14–0.39)
Iran (Islamic Republic of) 0.67 5621 10.72 8705 12.24 0.14 4043 15.36 5878 16.58 0.08 1578 5.98 2827 7.94 0.33
(5345–5896) (10.12–11.25) (8040–9366) (11.26–13.16) (0.07–0.22) (3833–4244) (14.51–16.12) (5357–6411) (15.1–18.09) (0–0.17) (1486–1666) (5.59–6.33) (2548–3081) (7.13–8.68) (0.19–0.45)
Iraq 0.671 2395 15.50 4154 18.69 0.21 1808 24.40 2997 28.37 0.16 587 7.15 1157 9.79 0.37
(1875–2958) (12.28–18.91) (3200–5129) (14.53–22.68) (0–0.46) (1380–2283) (18.91–30.38) (2290–3678) (21.98–34.02) (‐0.05–0.45) (447–756) (5.5–9.09) (880–1475) (7.53–12.32) (0.08–0.76)
Philippines 0.623 9978 17.35 13 827 17.71 0.17 7244 27.40 9522 26.62 ‐0.03 2734 8.93 4305 10.38 0.16
(9081–11 179) (15.83–19.4) (11 026–17 100) (14.24–21.75) (‐0.03–0.38) (6420–8373) (24.42–31.58) (7205–12 395) (20.36–34.23) (‐0.29–0.27) (2428–3108) (7.96–10.1) (3199–5617) (7.79–13.4) (‐0.15–0.56)
Syrian Arab Republic 0.619 1167 11.71 1372 11.09 ‐0.05 873 16.49 991 15.37 ‐0.07 294 6.40 382 6.61 0.03
(954–1400) (9.68–13.97) (1007–1814) (8.24–14.52) (‐0.28–0.22) (702–1070) (13.34–20.1) (720–1313) (11.3–20.13) (‐0.31–0.23) (239–354) (5.28–7.58) (262–519) (4.56–8.78) (‐0.26–0.36)
Thailand 0.687 17 710 24.56 22 545 22.24 ‐0.09 11 686 35.60 14 701 31.98 ‐0.10 6023 15.44 7845 14.17 ‐0.08
(15 447–19 944) (21.44–27.57) (17 018–29 560) (16.78–29.04) (‐0.33–0.2) (9968–13 420) (30.55–40.69) (10 810–19 418) (23.67–42.06) (‐0.34–0.23) (5229–6868) (13.37–17.66) (5967–10 297) (10.77–18.62) (‐0.33–0.22)
Turkmenistan 0.67 262 8.51 413 9.90 0.16 197 14.51 311 16.65 0.15 66 3.86 102 4.57 0.19
(248–276) (8.04–8.97) (326–521) (7.84–12.37) (‐0.08–0.46) (184–209) (13.58–15.43) (242–395) (13.16–20.87) (‐0.1–0.44) (59–72) (3.49–4.27) (79–130) (3.56–5.83) (‐0.06–0.48)
Uzbekistan 0.631 1825 11.77 2771 12.67 0.08 1333 19.63 1992 20.46 0.04 493 5.81 779 6.73 0.16
(1741–1915) (11.25–12.31) (2282–3324) (10.65–14.92) (‐0.1–0.27) (1253–1414) (18.57–20.78) (1620–2421) (17.03–24.28) (‐0.14–0.24) (464–523) (5.47–6.2) (638–942) (5.58–7.99) (‐0.04–0.39)
Vietnam 0.617 17 235 24.83 25 550 26.72 0.08 12 590 42.65 18 528 44.80 0.05 4645 11.81 7022 13.29 0.13
(15 159–19 723) (22.04–28.24) (19 741–32 387) (20.83–33.51) (‐0.13–0.3) (11 087–14 260) (38.09–47.93) (14 064–23 736) (34.83–56.18) (‐0.15–0.28) (3843–5618) (9.79–14.37) (5269–9137) (9.98–17.24) (‐0.12–0.41)
Low‐middle SDI
Bangladesh 0.483 6566 7.64 9652 7.43 ‐0.03 5397 11.69 7502 11.08 ‐0.05 1169 2.90 2150 3.43 0.18
(4863–8976) (5.7–10.28) (6331–15 120) (4.91–11.56) (‐0.28–0.27) (3987–7425) (8.74–15.83) (4817–12 048) (7.15–17.71) (‐0.33–0.26) (801–1657) (1.97–4.14) (1422–3061) (2.26–4.91) (‐0.09–0.49)
Bhutan 0.455 32 7.24 43 7.73 0.07 24 10.64 31 11.08 0.04 8 3.61 12 4.25 0.18
(24–41) (5.44–9.48) (31–58) (5.57–10.59) (‐0.11–0.28) (16–32) (7.04–14.45) (20–44) (7.06–15.83) (‐0.14–0.25) (5–13) (2.36–6.02) (8–18) (2.88–6.69) (‐0.04–0.47)
Cambodia 0.469 1943 23.27 2888 24.71 0.06 1444 42.72 2091 44.38 0.04 499 10.00 796 11.58 0.16
(1615–2410) (19.41–29.44) (2267–3576) (19.4–30.59) (‐0.12–0.26) (1172–1852) (34.7–55.69) (1607–2668) (34.42–57.78) (‐0.14–0.24) (408–613) (8.27–12.25) (609–1018) (8.95–14.76) (‐0.06–0.41)
Democratic People's Republic of Korea 0.558 7716 28.48 9042 27.88 ‐0.02 5232 49.12 6058 45.66 ‐0.07 2484 15.64 2984 15.88 0.02
(5937–9904) (22.28–36.22) (7008–11 461) (21.77–35.2) (‐0.17–0.14) (3767–7144) (36.39–65.33) (4408–8117) (33.78–59.94) (‐0.21–0.1) (1904–3102) (12.08–19.45) (2144–3880) (11.37–20.73) (‐0.19–0.24)
India 0.566 58 555 6.95 87 339 7.70 0.11 44 441 10.80 61 253 11.16 0.03 14 113 3.30 26 086 4.49 0.36
(53 880–63 454) (6.38–7.52) (71 865–103 504) (6.36–9.1) (‐0.09–0.31) (40 224–48 717) (9.74–11.84) (48 085–75 929) (8.8–13.74) (‐0.19–0.27) (12 387–15 766) (2.88–3.7) (20 315–32 542) (3.51–5.59) (0.06–0.71)
Kyrgyzstan 0.596 464 13.08 569 12.20 0.01 358 23.41 430 21.29 ‐0.09 106 5.22 139 5.37 0.03
(444–483) (12.5–13.63) (493–647) (10.62–13.86) (‐0.19–0.27) (340–374) (22.28–24.5) (371–492) (18.45–24.33) (‐0.21–0.04) (99–113) (4.85–5.59) (115–164) (4.47–6.31) (‐0.14–0.21)
Lao People's Democratic Republic 0.49 714 22.07 973 22.78 0.01 539 35.53 713 35.30 ‐0.01 174 10.05 260 11.45 0.14
(549–920) (17.04–28.22) (718–1264) (17.04–29.01) (‐0.17–0.22) (402–723) (26.79–47.27) (519–923) (26.3–44.79) (‐0.2–0.22) (134–247) (7.83–14.21) (186–372) (8.37–16.54) (‐0.09–0.41)
Maldives 0.562 18 9.88 26 9.58 ‐0.02 14 14.24 20 13.74 ‐0.04 4 4.54 6 4.83 0.06
(16–20) (8.82–11.02) (22–32) (7.88–11.42) (‐0.17–0.14) (12–16) (12.47–16.19) (17–24) (11.12–16.56) (‐0.22–0.18) (3–4) (3.88–5.24) (5–8) (3.86–5.91) (‐0.14–0.31)
Mongolia 0.606 436 30.80 662 31.19 ‐0.07 342 56.92 521 58.13 0.02 94 12.49 141 12.53 0.00
(360–520) (25.83–36.06) (512–863) (24.67–39.68) (‐0.27–0.16) (280–412) (47.51–67.06) (391–686) (44.99–74.31) (‐0.21–0.29) (77–115) (10.34–15.05) (109–182) (9.93–15.84) (‐0.22–0.28)
Myanmar 0.521 7977 22.49 10 291 22.43 ‐0.03 5560 35.70 6983 35.42 ‐0.01 2417 12.20 3308 12.78 0.05
(5874–11 118) (16.61–31.11) (7608–14 071) (16.85–30.17) (‐0.2–0.17) (3740–8705) (24.28–55.37) (4957–10 306) (25.24–51.86) (‐0.2–0.23) (1893–3145) (9.51–16.02) (2559–4360) (9.87–16.75) (‐0.13–0.27)
Palestine 0.588 318 19.25 523 22.53 ‐0.05 252 34.39 410 38.02 0.11 66 7.17 113 9.15 0.27
(288–348) (17.43–21.05) (444–613) (19.09–26.1) (‐0.28–0.27) (226–280) (30.8–38.2) (349–478) (32.52–43.98) (‐0.09–0.32) (59–76) (6.29–8.2) (92–137) (7.46–10.99) (0.01–0.59)
Tajikistan 0.539 481 12.86 593 11.98 ‐0.07 355 19.54 411 17.78 ‐0.09 125 6.50 182 6.80 0.05
(415–555) (11.02–14.91) (479–740) (9.76–14.83) (‐0.27–0.17) (300–416) (16.35–22.98) (323–527) (14.3–22.37) (‐0.29–0.16) (108–145) (5.59–7.55) (146–229) (5.48–8.49) (‐0.18–0.32)
Timor‐Leste 0.514 108 17.36 158 19.48 0.12 79 25.16 113 28.08 0.12 30 9.47 46 11.12 0.17
(77–142) (12.32–22.53) (113–207) (13.86–25.27) (‐0.12–0.39) (52–105) (16.6–33.1) (75–148) (18.7–36.55) (‐0.13–0.41) (22–47) (7.2–15.05) (32–66) (7.93–15.99) (‐0.11–0.49)
Low SDI
Afghanistan 0.343 1102 11.67 1476 11.74 0.01 873 19.77 1111 19.22 ‐0.03 229 4.29 365 5.10 0.19
(622–1880) (6.83–19.97) (871–2335) (7.33–18.53) (‐0.17–0.27) (458–1626) (10.56–36.59) (618–1928) (11.28–33.01) (‐0.2–0.24) (158–330) (3.13–6.1) (237–524) (3.62–7.06) (‐0.08–0.53)
Nepal 0.422 1176 7.04 1759 8.03 0.00 839 10.15 1202 11.51 0.13 337 3.97 557 4.84 0.22
(862–1552) (5.13–9.3) (1263–2275) (5.86–10.37) (‐0.18–0.22) (619–1110) (7.53–13.39) (873–1535) (8.4–14.59) (‐0.12–0.39) (212–508) (2.46–6.09) (371–803) (3.22–7.03) (‐0.04–0.57)
Pakistan 0.449 14 621 17.38 18 401 16.43 ‐0.18 12 630 28.75 15 424 26.67 ‐0.07 1991 4.94 2978 5.50 0.11
(11 540–18 092) (13.79–21.4) (13 970–24 265) (12.47–21.49) (‐0.32–0.02) (9607–16 079) (22.1–36.25) (11 224–21 011) (19.52–36.05) (‐0.34–0.29) (1564–2433) (3.86–6) (2160–3927) (4.05–7.16) (‐0.17–0.5)
Yemen 0.412 952 10.13 1302 9.95 ‐0.02 766 16.44 1014 15.94 ‐0.03 186 3.83 289 4.15 0.09
(684–1373) (7.29–14.61) (885–1930) (6.8–14.67) (‐0.21–0.21) (532–1136) (11.48–24.16) (658–1601) (10.39–24.91) (‐0.24–0.21) (141–250) (2.9–5.03) (212–391) (3.11–5.57) (‐0.21–0.36)

Abbreviations: CI, confidence interval; SDI, sociodemographic index; TBL, tracheal, bronchial and lung.

National comparison

Among Asian countries, 20 countries experienced an increasing trend in the TBL cancer morbidity rate between 2010 and 2019; the greatest increase was detected in Iraq (increase in ASIR = 0.21 [95% CI: 0–0.46]) and the greatest decrease was detected in the United Arab Emirates (decrease in ASIR = −0.18 [95% CI: −0.37–0.06]) (Figure 4).

FIGURE 4.

FIGURE 4

The relative change (%) in age‐standardized incidence rate (ASIR), age‐standardized death rate (ASMR), age‐standardized DALYs rate (DALYs ASR), and age‐standardized prevalence rate (ASPR) of TBL cancer in Asian countries from 1990 to 2019.

In 2019, the highest ASIR (per 100 000) of TBL cancer was reported in Brunei Darussalam (46.15), China (41.71), the Republic of Korea (35.61), Turkey (33.08), and Taiwan (Province of China) (31.88). The lowest ASIR of TBL cancer was reported in Bangladesh (7.43), India (7.7), Bhutan (7.73), Nepal (8.03), and Saudi Arabia (8.77). The national distribution of TBL cancer among men and women was the same as the overall distribution; however, men in Georgia had the highest ASIR rate (62.13). Detailed results are presented in Table 4.

Mortality of TBL cancer in Asia

Compared with global data and continents

In Asia, the number of TBL cancer deaths increased from 906 650 (95% CI: 846 561–964 850) in 2010 to 1 190 516 (95% CI: 1 052 836–1 330 529) in 2019, which is over a 1.31‐fold increase. In 2019 more than 58% (1 190 516/2 042 640) of TBL cancer deaths happened in Asian countries. During this period, the ASDR of TBL cancer with a 3% change, decreased from 26.66 (95% CI: 24.77–28.33) per 100 000 in 2010 to 25.76 (95% CI: 22.79–28.72) per 100 000 in 2019, while in the same time, this rate globally decreased by 6%, in America by 10%, and in Europe by 8% (Figure 1 and Table 1).

In Asian men, the number of TBL cancer deaths increased from 646 099 (95% CI: 599 147–694 710) in 2010 to 825 738 (95% CI: 706 207–949 796) in 2019, which is over a 1.28‐fold increase. In 2019 approximately 69.4% of Asian TBL cancer deaths occurred in Asian men which included 60% (825 738/1 386 094) of global male TBL cancer death cases. During this period, the ASDR of TBL cancer with a 6% change, decreased from 40.66 (95% CI: 37.75–43.57) per 100 000 in 2010 to 38.3 (95% CI: 33–43.79) per 100 000 in 2019, while in the same time, this rate globally decreased by 9%, in America by 12% and in Europe by 13% (Table 2).

In Asian women, the number of TBL cancer deaths increased from 260 550 (95% CI: 238 233–282 526) in 2010 to 364 778 (95% CI: 312 089–421 085) in 2019, which is over a 1.4‐fold increase. In 2019 approximately 30.6% of Asian TBL cancer deaths occurred in Asian women which included 55.6% (364 778 /656 546) of global female TBL cancer incidence cases. During this period, the age‐standardized incidence rate (ASIR) of TBL cancer with a 2% change, increased from 14.67 (95% CI: 13.35–15.92) per 100 000 in 2010 to 14.98 (95% CI: 12.81–17.27) per 100 000 in 2019, while in the same time, this rate globally experienced no changes, in Africa increased by 12%, and in Europe by 2%; while in American countries decreased by 8% (Table 3).

Age distribution

In 2019, age‐specific death cases of TBL cancer were peaking at 70–74 years generally, in males, and females. In all age groups, death cases of TBL cancer in males were higher than in females, except in ages above 90 years which in females was higher (Figure 5).

FIGURE 5.

FIGURE 5

Age specific death cases of TBL cancer among sexes in Asia, 2019.

Within Asian regions

In 2019, the highest ASDR of TBL was observed in East Asian countries (38.38 [95% CI: 32.72–44.57]); with a 4% decrease compared with 2010. While the Central Asia and high‐income Asia Pacific countries experienced a decreasing trend of 7% and 11%, respectively; the South Asian countries experienced the highest increasing trend from 2010 to 2019 (by 6%) (Figure 3 and Table 1).

In men, the highest ASDR of TBL was observed in East Asia countries (57.5 [95% CI: 46.25–69.74]); with a 5% decrease compared with 2010. While Central Asia, High‐income Asia Pacific, North Africa and Middle East countries experienced a decreasing trend of 9, 15, and 3%, respectively; the South Asian and Southeast Asian countries experienced a stable trend from 2010 to 2019 (Table 2).

In women, the highest ASDR of TBL was observed in Southeast Asian countries (13.36 [95% CI: 10.19–16.57]) in 2019; other countries experienced an increasing trend from 2010 to 2019, except high‐income Asia Pacific countries who experienced a decreasing trend by 3% from 2010 to 2019 and East Asia experienced a stable trend. Other countries experienced an increasing trend from 2% to 31%. South Asian countries experienced the highest increasing trend from 2010 to 2019 (by 31%) (Table 3).

Based on SDI

Among high SDI Asian countries, Brunei Darussalam (44.83) and Taiwan (Province of China) (30.35) had the highest ASDR of TBL, and Saudi Arabia (9.14) had the lowest rate. Among high‐middle SDI Asian countries, Turkey (33.77) and Georgia (30.57) had the highest ASDR of TBL, and Sri Lanka (9.78) had the lowest rate. Among middle SDI Asian countries, China (38.70) and Armenia (31.62) had the highest ASIR of TBL, and Turkmenistan (9.86) had the lowest rate. Among low‐middle SDI Asian countries, Mongolia (33.35) and the Democratic People's Republic of Korea (28.54) had the highest ASDR of TBL, and Bangladesh (7.81) had the lowest rate. Among low SDI Asian countries, Pakistan (17.16) had the highest ASDR of TBL, and Nepal (8.62) had the lowest rate. Further details are presented in Table 5.

TABLE 5.

The death distribution of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Both Male Female
Location SDI 2019 2010 2019 % change 2010–2010 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
High SDI
Brunei Darussalam 0.823 69 45.89 103 44.83 ‐0.02 39 60.935874 57 61.11 0.00 30 35.25 47 5.76 0.02
(63–76) (41.83–49.96) (92–116) (39.66–50.19) (‐0.14–0.11) (35–44) (53.69–68.48) (47–67) (51.96–71.14) (‐0.16–0.18) (27–33) (31.44–39.05) (40–54) (4.23–7.59) (‐0.13–0.2)
Cyprus 0.841 362 25.56 462 23.42 ‐0.08 283 44.832451 358 38.37 ‐0.14 79 10.36 104 11.76 ‐0.01
(340–385) (24–27.22) (404–525) (20.52–26.63) (‐0.21–0.05) (264–305) (41.76–48.26) (309–412) (33.08–44.39) (‐0.27–0) (71–87) (9.4–11.38) (88–121) (8.38–16.83) (‐0.17–0.13)
Israel 0.803 2084 23.74 2518 21.69 ‐0.09 1391 35.486246 1651 31.35 ‐0.12 692 14.02 867 13.53 ‐0.04
(1963–2166) (22.44–24.64) (2314–2684) (20.04–23.1) (‐0.14–‐0.03) (1320–1451) (33.69–37) (1526–1769) (29.01–33.63) (‐0.17–‐0.05) (633–735) (12.95–14.82) (769–953) (10.5–17.71) (‐0.12–0.04)
Japan 0.87 77 446 23.94 86 001 21.21 ‐0.11 55 542 41.086896 59 128 34.43 ‐0.16 21 904 11.34 26 873 13.46 ‐0.04
(68 445–82 060) (21.57–25.15) (73 379–92 677) (18.86–22.52) (‐0.14–‐0.09) (50 829–57 902) (37.63–42.84) (52 951–62 882) (31.29–36.42) (‐0.19–‐0.14) (17 457–24 307) (9.57–12.3) (20 579–30 319) (10.15–17.38) (‐0.07–0)
Kuwait 0.851 133 10.71 228 10.75 0.00 104 13.622346 181 14.51 0.07 29 5.86 47 7.64 ‐0.15
(123–142) (9.82–11.46) (185–275) (8.72–12.98) (‐0.18–0.21) (95–112) (12.47–14.67) (140–225) (11.28–18.13) (‐0.16–0.34) (26–32) (5.19–6.45) (37–59) (6.43–8.89) (‐0.32–0.04)
Qatar 0.83 66 23.82 119 20.74 ‐0.13 56 28.944687 101 23.78 ‐0.18 10 12.55 18 6.89 ‐0.06
(53–81) (19.57–28.75) (85–165) (16–26.07) (‐0.32–0.11) (44–71) (23.08–35.69) (70–144) (18.07–30.42) (‐0.39–0.1) (8–12) (10.07–15.24) (14–23) (5.75–8.14) (‐0.24–0.16)
Republic of Korea 0.878 17 173 28.48 23 300 26.30 ‐0.08 12 516 51.709606 16 614 44.73 ‐0.13 4658 13.36 6686 5.07 ‐0.02
(16 151–18 288) (26.55–30.46) (20 864–25 565) (23.51–28.95) (‐0.15–0) (11 907–13 376) (48.53–55.26) (14 800–18 406) (39.53–49.69) (‐0.22–‐0.04) (4138–5002) (11.84–14.43) (5681–7580) (4.04–6.2) (‐0.12–0.09)
Saudi Arabia 0.805 1026 9.67 1492 9.14 ‐0.05 779 13.087167 1110 11.67 ‐0.11 247 5.16 382 16.51 0.03
(911–1186) (8.74–10.97) (1146–1830) (7.33–11.06) (‐0.23–0.13) (692–914) (11.82–15.09) (842–1380) (9.15–14.5) (‐0.29–0.1) (215–283) (4.51–5.86) (286–493) (12.14–22.82) (‐0.21–0.29)
Singapore 0.861 1180 25.62 1566 20.89 ‐0.18 779 38.33246 1010 29.36 ‐0.23 401 15.82 556 12.13 ‐0.12
(1106–1228) (23.72–26.8) (1414–1682) (18.7–22.48) (‐0.24–‐0.13) (736–812) (35.88–40.11) (915–1087) (26.4–31.74) (‐0.3–‐0.18) (363–430) (14.22–16.98) (476–621) (9.35–15.37) (‐0.21–‐0.03)
Taiwan (Province of China) 0.868 9477 31.76 12 053 30.35 ‐0.04 6275 43.334223 7526 41.31 ‐0.05 3201 20.89 4527 5.15 0.01
(8860–9886) (29.66–33.13) (9527–15 345) (24.07–38.58) (‐0.24–0.21) (5890–6556) (40.7–45.28) (5915–9577) (32.49–52.51) (‐0.25–0.21) (2911–3386) (18.96–22.13) (3521–5766) (3.38–7.58) (‐0.2–0.29)
United Arab Emirates 0.88 221 25.27 523 20.35 ‐0.19 172 28.051538 423 23.74 ‐0.15 49 20.31 100 13.55 ‐0.33
(177–267) (20.93–29.73) (380–697) (14.71–28.22) (‐0.38–0.06) (136–211) (22.57–34.14) (303–580) (17.44–32.88) (‐0.33–0.09) (38–60) (16.3–24.84) (66–135) (7.93–20.63) (‐0.6–0.08)
High‐middle SDI
Bahrain 0.751 86 27.19 142 22.08 ‐0.19 64 39.55 106 30.42 ‐0.23 22 15.08 35 10.91 ‐0.14
(76–97) (24–30.54) (107–187) (17.07–27.74) (‐0.36–0.01) (55–74) (34.23–45.28) (78–144) (22.96–39.13) (‐0.41–0) (19–26) (13.06–17.35) (28–43) (9.02–12) (‐0.3–0.04)
Georgia 0.702 1659 28.83 1770 30.57 0.06 1392 57.63 1496 61.47 0.07 267 7.74 274 12.19 0.03
(1512–1806) (26.19–31.44) (1485–2080) (25.58–36.05) (‐0.13–0.28) (1248–1533) (51.79–63.61) (1241–1764) (51.26–72.48) (‐0.13–0.29) (242–293) (7.01–8.52) (230–329) (9.55–15.44) (‐0.17–0.25)
Jordan 0.731 492 16.12 917 15.11 ‐0.06 394 24.90 711 22.35 ‐0.10 98 6.54 206 7.21 0.10
(437–554) (14.4–18.16) (749–1110) (12.47–18.25) (‐0.24–0.14) (347–451) (21.91–28.36) (551–897) (17.53–27.92) (‐0.3–0.13) (84–113) (5.61–7.63) (163–261) (5.7–9.09) (‐0.12–0.4)
Kazakhstan 0.723 3707 26.06 3717 21.14 ‐0.19 3023 53.60 2949 41.77 ‐0.22 684 8.18 768 9.16 ‐0.07
(3528–3903) (24.81–27.42) (3184–4261) (18.19–24.13) (‐0.31–‐0.06) (2849–3222) (50.5–56.9) (2501–3441) (35.55–48.3) (‐0.34–‐0.09) (644–724) (7.72–8.65) (646–894) (7.1–11.7) (‐0.22–0.1)
Lebanon 0.708 1233 28.99 1433 27.51 ‐0.05 901 43.86 961 40.95 ‐0.07 332 15.21 472 13.69 0.09
(1055–1587) (24.77–37.45) (1184–1898) (22.67–36.43) (‐0.19–0.1) (750–1179) (36.6–57.8) (768–1281) (32.73–54.66) (‐0.21–0.11) (278–431) (12.73–19.7) (347–656) (10.94–17.28) (‐0.17–0.3)
Malaysia 0.737 3987 22.70 5221 20.60 ‐0.09 2788 32.03 3689 29.23 ‐0.09 1199 13.73 1532 12.07 ‐0.12
(3634–4394) (20.65–25.05) (4060–6639) (16.01–25.95) (‐0.29–0.13) (2532–3082) (28.86–35.47) (2834–4679) (22.62–37.18) (‐0.29–0.15) (1085–1335) (12.35–15.43) (1177–1946) (8.92–17.44) (‐0.31–0.1)
Oman 0.783 120 12.61 144 10.45 ‐0.17 90 17.49 103 14.17 ‐0.19 30 6.91 42 13.13 ‐0.04
(109–131) (11.49–13.75) (115–187) (8.67–12.59) (‐0.31–0.02) (81–100) (15.76–19.37) (77–143) (11.41–18.04) (‐0.36–0.04) (26–34) (5.96–7.91) (30–50) (11.21–14.86) (‐0.26–0.15)
Sri Lanka 0.69 1958 10.37 2478 9.78 ‐0.06 1438 16.86 1704 15.17 ‐0.10 520 5.14 774 11.80 0.08
(1845–2082) (9.75–11.02) (1804–3369) (7.17–13.16) (‐0.3–0.26) (1329–1540) (15.56–18.17) (1181–2405) (10.71–20.97) (‐0.36–0.25) (475–570) (4.7–5.64) (570–1018) (9.31–14.65) (‐0.2–0.4)
Turkey 0.748 23 677 35.27 29 832 33.77 ‐0.04 20 121 64.00 24 781 59.69 ‐0.07 3556 10.04 5051 6.60 0.09
(20 919–26 663) (31.17–39.67) (23 752–37 028) (26.89–41.8) (‐0.25–0.23) (17 682–22 813) (56.28–72.42) (19 591–30 951) (47.29–74.06) (‐0.28–0.21) (3109–4051) (8.77–11.45) (4027–6271) (4.98–7.96) (‐0.15–0.39)
Middle SDI
Armenia 0.689 1318 35.17 1334 31.62 ‐0.10 1084 68.17 1091 60.65 ‐0.11 234 10.84 243 13.41 ‐0.06
(1259–1380) (33.7–36.83) (1122–1578) (26.67–37.28) (‐0.24–0.06) (1035–1140) (65.21–71.66) (916–1296) (51.04–71.69) (‐0.25–0.05) (219–249) (10.16–11.57) (202–285) (11.96–14.7) (‐0.22–0.12)
Azerbaijan 0.683 1718 23.64 2296 23.58 0.00 1376 41.67 1852 41.55 0.00 342 8.96 444 5.58 0.02
(1462–1949) (20.17–26.79) (1687–2921) (17.54–29.65) (‐0.19–0.22) (1123–1599) (34.32–48.26) (1253–2449) (28.54–53.95) (‐0.23–0.27) (295–398) (7.6–10.43) (346–567) (4.12–7.34) (‐0.18–0.27)
China 0.686 576 914 40.32 757 171 38.70 ‐0.04 407 013 61.44 523 192 58.10 ‐0.05 169 901 22.95 233 980 13.86 0.00
(525 378–627 888) (36.72–43.74) (638 741–887 752) (32.8–45.03) (‐0.2–0.14) (364 221–453 597) (55.4–67.89) (413 189–647 410) (46.53–70.89) (‐0.25–0.18) (151 510–187 913) (20.52–25.38) (189 176–282 754) (11.9–15.47) (‐0.21–0.23)
Indonesia 0.66 35 895 22.85 49 437 24.43 0.07 24 808 34.01 33 792 35.81 0.05 11 086 13.29 15 645 3.62 0.11
(29 166–41 844) (18.64–26.48) (36 066–61 105) (17.87–30.22) (‐0.12–0.25) (20 169–30 290) (28.07–40.5) (24 844–44 220) (27.13–45.72) (‐0.18–0.34) (6893–15 503) (8.37–18.31) (8696–23 612) (2.36–5.2) (‐0.13–0.37)
Iran (Islamic Republic of) 0.67 5820 11.43 8923 12.88 0.13 4251 16.54 6155 17.78 0.07 1569 6.19 2768 10.93 0.30
(5524–6094) (10.75–11.99) (8247–9595) (11.86–13.89) (0.06–0.21) (4013–4451) (15.54–17.35) (5636–6725) (16.23–19.41) (0–0.16) (1478–1653) (5.77–6.54) (2488–3018) (8.44–13.91) (0.16–0.42)
Iraq 0.671 2439 16.40 4232 19.86 0.21 1862 26.22 3106 30.87 0.18 577 7.29 1125 16.34 0.36
(1919–2991) (13.04–19.86) (3275–5190) (15.62–23.82) (0.01–0.46) (1430–2338) (20.5–32.43) (2375–3782) (24.16–36.78) (‐0.03–0.46) (441–738) (5.65–9.2) (861–1428) (11.79–21.14) (0.08–0.74)
Philippines 0.623 10 071 18.10 13 964 18.47 0.02 7292 28.64 9574 27.81 ‐0.03 2779 9.40 4391 36.09 0.16
(9171–11 304) (16.52–20.33) (11 342–17 103) (15.13–22.39) (‐0.18–0.24) (6473–8370) (25.5–32.82) (7259–12 342) (21.32–35.44) (‐0.26–0.25) (2482–3134) (8.41–10.6) (3359–5627) (30.48–41.95) (‐0.13–0.53)
Syrian Arab Republic 0.619 1163 12.34 1374 11.62 ‐0.06 883 17.36 1007 16.16 ‐0.07 280 6.69 368 5.33 0.02
(951–1394) (10.22–14.66) (1011–1813) (8.7–15.09) (‐0.28–0.2) (713–1080) (14.13–21.12) (735–1330) (11.92–21.03) (‐0.31–0.22) (229–337) (5.52–7.91) (251–496) (3.89–7.3) (‐0.26–0.33)
Thailand 0.687 18 077 25.63 23 109 22.96 ‐0.10 11 877 37.26 14 984 33.14 ‐0.11 6200 16.16 8125 4.70 ‐0.09
(15 773–20 299) (22.28–28.73) (17 523–30 148) (17.39–29.79) (‐0.33–0.18) (10 169–13 616) (31.81–42.52) (11 049–19 714) (24.72–43.49) (‐0.35–0.21) (5362–7096) (13.93–18.5) (6109–10 606) (3.69–5.87) (‐0.33–0.2)
Turkmenistan 0.67 255 8.52 399 9.86 0.16 191 14.68 300 16.74 0.14 64 3.88 99 9.30 0.17
(242–268) (8.04–8.99) (316–504) (7.82–12.24) (‐0.08–0.45) (179–203) (13.73–15.6) (234–380) (13.32–20.9) (‐0.1–0.43) (58–71) (3.5–4.29) (77–126) (7.6–11.15) (‐0.07–0.47)
Uzbekistan 0.631 1777 12.10 2656 12.93 0.07 1299 20.34 1912 20.99 0.03 479 6.03 744 4.34 0.14
(1697–1861) (11.6–12.67) (2189–3179) (10.95–15.15) (‐0.1–0.26) (1220–1375) (19.23–21.51) (1564–2316) (17.52–24.9) (‐0.15–0.23) (451–508) (5.67–6.43) (612–898) (3.25–5.81) (‐0.05–0.37)
Vietnam 0.617 17 351 25.40 25 161 26.98 0.06 12 611 44.08 18 151 45.80 0.04 4741 12.13 7010 5.31 0.11
(15 352–19 780) (22.5–28.76) (19 494–31 704) (21.12–33.59) (‐0.14–0.28) (11 157–14 257) (39.47–49.43) (13 927–23 007) (35.79–57.02) (‐0.16–0.25) (3943–5695) (10.14–14.62) (5288–9118) (4.06–6.69) (‐0.13–0.38)
Low‐middle SDI
Bangladesh 0.483 6743 8.11 9970 7.81 ‐0.04 5553 12.39 7765 11.63 ‐0.06 1190 3.09 2206 10.23 0.17
(5015–9167) (6.03–10.91) (6569–15 550) (5.19–12.13) (‐0.29–0.26) (4139–7591) (9.3–16.69) (5023–12 476) (7.59–18.55) (‐0.34–0.26) (810–1679) (2.07–4.43) (1454–3162) (8.52–12.03) (‐0.09–0.46)
Bhutan 0.455 33 7.75 44 8.26 0.07 25 11.44 33 11.87 0.04 8 3.84 12 8.03 0.17
(25–43) (5.8–10.14) (32–61) (5.99–11.35) (‐0.11–0.27) (17–34) (7.51–15.45) (21–46) (7.58–16.84) (‐0.14–0.25) (5–13) (2.53–6.37) (8–19) (7.19–8.8) (‐0.04–0.46)
Cambodia 0.469 2022 25.00 2985 26.38 0.05 1511 46.42 2169 47.99 0.03 510 10.54 816 9.90 0.16
(1683–2527) (20.87–31.72) (2340–3699) (20.84–32.64) (‐0.12–0.25) (1224–1953) (37.87–61.36) (1672–2792) (37.23–62.64) (‐0.14–0.24) (420–626) (8.75–12.92) (629–1048) (7.7–12.23) (‐0.06–0.41)
Democratic People's Republic of Korea 0.558 7796 29.26 9163 28.54 ‐0.02 5238 51.31 6072 47.49 ‐0.07 2558 16.21 3091 7.96 0.01
(6038–9952) (23.13–36.87) (7158–11 540) (22.5–35.77) (‐0.16–0.14) (3795–7105) (38.38–67.9) (4439–8075) (35.33–61.49) (‐0.21–0.09) (1988–3187) (12.68–20.03) (2235–3985) (6.61–9.56) (‐0.19–0.22)
India 0.566 59 637 7.31 89 242 8.07 0.10 45 272 11.38 62 544 11.73 0.03 14 365 3.47 26 698 22.86 0.35
(55 118–64 928) (6.72–7.96) (73 675–105 403) (6.65–9.49) (‐0.09–0.3) (40 946–50 024) (10.27–12.56) (49 134–76 427) (9.25–14.32) (‐0.19–0.27) (12 383–16 094) (2.97–3.93) (20 990–33 532) (18.52–27.52) (0.04–0.7)
Kyrgyzstan 0.596 463 13.28 560 12.35 ‐0.07 354 23.76 422 21.60 ‐0.09 108 5.40 139 10.21 0.02
(443–481) (12.7–13.83) (486–636) (10.8–14.02) (‐0.19–0.05) (337–370) (22.63–24.86) (364–483) (18.79–24.65) (‐0.21–0.04) (101–116) (5.03–5.78) (115–163) (8.66–11.83) (‐0.15–0.2)
Lao People's Democratic Republic 0.49 735 23.51 1000 24.28 0.03 558 38.21 736 37.99 ‐0.01 177 10.56 264 4.55 0.14
(567–944) (18.32–29.96) (742–1290) (18.33–30.73) (‐0.15–0.25) (418–746) (29.15–50.58) (538–944) (28.33–48.32) (‐0.19–0.21) (137–251) (8.33–14.96) (191–380) (3.59–5.73) (‐0.08–0.41)
Maldives 0.562 19 10.71 27 10.19 ‐0.05 15 15.42 21 14.67 ‐0.05 4 4.86 6 14.71 0.04
(17–21) (9.55–11.95) (22–32) (8.37–12.12) (‐0.22–0.14) (13–17) (13.54–17.52) (17–25) (11.9–17.69) (‐0.23–0.16) (3–5) (4.14–5.62) (5–8) (8.21–21.61) (‐0.16–0.3)
Mongolia 0.606 444 32.91 672 33.35 0.01 346 61.58 525 62.75 0.02 98 13.68 146 14.65 0.00
(368–528) (27.71–38.32) (523–869) (26.47–41.97) (‐0.19–0.25) (284–415) (51.74–72.13) (397–686) (49.16–79.39) (‐0.2–0.28) (81–120) (11.37–16.36) (114–188) (11.02–19.14) (‐0.21–0.26)
Myanmar 0.521 8280 23.93 10 614 23.80 ‐0.01 5780 38.31 7195 37.84 ‐0.01 2500 12.90 3419 7.07 0.05
(6111–11 662) (17.77–33.42) (7896–14 368) (17.76–31.88) (‐0.17–0.22) (3900–9101) (25.96–59.89) (5113–10 591) (27.01–55.32) (‐0.19–0.22) (1957–3185) (10.04–16.86) (2644–4499) (5.71–8.81) (‐0.13–0.29)
Palestine 0.588 327 20.51 530 23.83 0.16 261 37.39 420 41.19 0.10 66 7.40 110 5.50 0.26
(296–357) (18.54–22.39) (448–618) (20.24–27.6) (‐0.04–0.38) (234–289) (33.48–41.42) (358–487) (35.31–47.72) (‐0.09–0.31) (58–75) (6.48–8.45) (90–133) (4.59–6.45) (‐0.01–0.57)
Tajikistan 0.539 480 13.31 586 12.57 ‐0.06 355 20.32 408 18.83 ‐0.07 124 6.72 178 4.96 0.05
(414–554) (11.39–15.41) (476–732) (10.27–15.51) (‐0.25–0.19) (300–416) (16.96–23.89) (322–522) (15.17–23.47) (‐0.28–0.18) (108–145) (5.76–7.81) (143–224) (3.95–6.14) (‐0.17–0.32)
Timor‐Leste 0.514 113 18.81 165 20.90 0.11 82 27.40 118 30.31 0.11 31 10.08 47 6.82 0.17
(80–148) (13.31–24.46) (116–216) (14.99–27.09) (‐0.12–0.37) (54–110) (18.17–35.66) (78–154) (20.01–39.3) (‐0.14–0.39) (23–49) (7.75–16.04) (33–67) (4.76–8.95) (‐0.11–0.47)
Low SDI
Afghanistan 0.343 1136 12.46 1492 12.53 0.01 908 21.10 1133 20.59 ‐0.02 228 4.48 359 13.04 0.19
(652–1939) (7.48–21.27) (892–2356) (7.99–19.7) (‐0.17–0.27) (482–1679) (11.52–38.64) (641–1954) (12.25–34.99) (‐0.19–0.24) (160–326) (3.3–6.35) (238–512) (10.45–15.76) (‐0.08–0.53)
Nepal 0.422 1225 7.55 1837 8.62 0.14 878 10.95 1263 12.43 0.13 347 4.22 574 4.50 0.22
(897–1614) (5.5–9.99) (1334–2371) (6.31–11.18) (‐0.1–0.4) (647–1161) (8.12–14.42) (917–1608) (9.07–15.75) (‐0.12–0.39) (217–528) (2.6–6.55) (382–830) (3.1–7.16) (‐0.05–0.58)
Pakistan 0.449 14 819 18.22 18 550 17.16 ‐0.06 12 810 30.17 15 555 27.89 ‐0.08 2009 5.18 2995 21.16 0.11
(11 510–18 507) (14.31–22.58) (14 209–23 969) (13.14–22.05) (‐0.28–0.25) (9608–16 488) (22.98–38.53) (11 375–20 942) (20.64–37.13) (‐0.33–0.27) (1606–2463) (4.14–6.31) (2197–3983) (16.49–27.08) (‐0.16–0.49)
Yemen 0.412 979 10.80 1336 10.61 ‐0.02 792 17.69 1047 17.12 ‐0.03 187 4.01 289 10.90 0.08
(703–1412) (7.75–15.53) (912–1972) (7.26–15.61) (‐0.21–0.21) (552–1167) (12.37–26.05) (681–1639) (11.19–26.67) (‐0.24–0.21) (142–251) (3.03–5.36) (214–390) (8.71–13.53) (‐0.21–0.35)

Abbreviations: CI, confidence interval; SDI, sociodemographic index; TBL, tracheal, bronchial and lung.

National comparison

Among Asian countries, 31 countries experienced a decreasing trend in the TBL cancer mortality rate between 2010 and 2019; the greatest increase was detected in Iraq (increase in ASDR = 0.21 [95% CI: 0.01–0.45]) and the greatest decrease was detected in the United Arab Emirates (decrease in ASDR = −0.18 [95% CI: −0.38–0.06]) (Figure 4).

In 2019, the highest ASDR (per 100 000) of TBL cancer was reported in Brunei Darussalam (44.83), China (38.7), Turkey (33.77), Mongolia (33.35), and Armenia (31.62). The lowest ASDR of TBL cancer was reported in Bangladesh (7.81), India (8.07), Bhutan (8.26), Nepal (8.62), and Saudi Arabia (9.14).

The national distribution of TBL cancer among men was the same as the overall distribution; however, men in Georgia had the second highest ASIR rate (61.47).

The national distribution of TBL cancer among women is different: the highest ASDR (per 100 000) of TBL cancer was reported in Brunei Darussalam (36.09), China (22.86), Taiwan (Province of China) (21.16), Lebanon (16.51), and Democratic People's Republic of Korea (16.34). The lowest ASDR (per 100 000) of TBL cancer was reported in Bangladesh (3.62), Yemen (4.34), Bhutan (4.5), Turkmenistan (4.55), and India (4.7). Detailed results are presented in Table 5.

Prevalence of TBL cancer in Asia

Compared with global data and continents

In Asia, the number of cases who lived with TBL cancer increased from 1 308 776 (95% CI: 1 225 459–1 392 332) in 2010 to 1 820 539 (95% CI: 1 605 530–2 034 496) in 2019, which is a 1.4‐fold increase. In 2019 approximately 57% (1 820 539/3 212 307) of TBL cancer prevalence happened in Asian countries. During this period, the ASPRof TBL cancer with a 4% change, increased from 36.35 (95% CI: 34.01–38.67) per 100 000 in 2010 to 37.81 (95% CI: 33.46–42.14) per 100 000 in 2019, while in the same time, this rate globally decreased by 2%, in America by 12%, and in Europe by 5% (Figure 1 and Table 1).

In Asian men, the number of TBL cancer prevalence increased from 928 147 (95% CI: 861 104–1 000 537) in 2010 to 1 257 715 (95% CI: 1 069 513–1 462 350) in 2019, which is over a 1.36‐fold increase. In 2019 approximately 69.1% of patients who lived with TBL cancer in Asia, were men which included 59.6% (1 257 715/2 109 409) of global male TBL cancer prevalence cases. During this period, the ASPR rate of TBL cancer with a 2% change, increased from 54.01 (95% CI: 50.08–58.12) per 100 000 in 2010 to 54.94 (95% CI: 46.96–63.32) per 100 000 in 2019, while in the same time, this rate globally decreased by 5%, in America by 11% and in Europe by 11% (Table 2).

In Asian women, the number of TBL cancer prevalence increased from 380 630 (95% CI: 349 763–411 327) in 2010 to 562 824 (95% CI: 480 164–653 889) in 2019, which is over a 1.48‐fold increase. In 2019 approximately 30.9% of patients who lived with TBL cancer in Asia, were women which included 51% (562 824/1 102 899) of global female TBL cancer prevalence cases. During this period, the ASPR of TBL cancer with a 10% change, increased from 20.43 (95% CI: 18.67–22.08) per 100 000 in 2010 to 22.49 (95% CI: 19.21–26.12) per 100 000 in 2019, while in the same time, this rate globally increased by 2%, in Africa by 14%, and in Europe by 5%; while in American countries decreased by 10% (Table 3).

Age distribution

In 2019, age‐specific prevalence cases of TBL cancer were peaking at 65–69 years generally, in males, and females. In all age groups, the prevalence cases of TBL cancer in males was higher than in females, except in ages above 95 years which in females was higher (Figure 6).

FIGURE 6.

FIGURE 6

Age specific prevalence cases of TBL cancer among sexes in Asia, 2019.

Within Asian regions

In 2019, the highest ASPR of TBL was observed in high‐income Asia Pacific countries (74.32 [95% CI: 63.96–85.75]); with an 8% decrease compared with 2010. While these countries and Central Asia countries experienced a decreasing trend of 8% and 5%, respectively, other Asian countries experienced an increasing trend from 2010 to 2019 (by 3%–11%) (Figure 3).

In men, the highest ASPR of TBL was observed in High‐income Asia Pacific countries at (114.22 [95% CI: 95.69–135.71]); with an 11% decrease compared with 2010. While these countries, Central Asia, and North Africa and Middle East countries experienced a decreasing trend of 11, 7, and 3%, respectively, other Asian countries experienced an increasing trend from 2010 to 2019 (by 1%–9%) (Table 2).

In women, the highest ASPR of TBL was observed in high‐income Asia Pacific countries (40.86 [95% CI: 34.13–48.03]); with a 1% decrease compared with 2010. Other countries experienced an increasing trend from 2010 to 2019 (by 6%–33%). The highest increase was reported in South Asian countries (33%). (Table 3).

Based on SDI

Among high SDI Asian countries, the Republic of Korea (75.66) and Japan (74.49) had the highest ASPR of TBL, and Saudi Arabia (9.01) had the lowest rate. Among high‐middle SDI Asian countries, Turkey (34.95) and Georgia (34.83) had the highest ASPR of TBL, and Oman (9.74) had the lowest rate. Among middle SDI Asian countries, China (55.13) and Armenia (35.13) had the highest ASPR of TBL, and Turkmenistan (10.826) had the lowest rate. Among low‐middle SDI Asian countries, Mongolia (29.55) and the Democratic People's Republic of Korea (29.05) had the highest ASPR of TBL, and Bangladesh (7.40) had the lowest rate. Among low SDI Asian countries, Pakistan (16.44) had the highest ASPR of TBL, and Nepal (7.71) had the lowest rate. Further details are presented in Table 6.

TABLE 6.

The prevalence of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Both Male Female
2010 2019 % change 2010‐2010 2010 2019 % change 2010‐2019 2010 2019 % change 2010‐2019
Location SDI 2019 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
High SDI
Brunei Darussalam 0.823 99 52.20 159 54.57 0.05 53 64.12 82 66.37 0.04 46 43.65 355 552 47.91 0.10
(91–109) (47.58–57.25) (139–180) (48.21–61.68) (‐0.1–0.2) (47–60) (56.81–72.81) (67–100) (54.72–78.31) (‐0.15–0.25) (41–52) (38.22–49.32) (283 761–437 708) (40.23–56.75) (‐0.1–0.33)
Cyprus 0.841 568 39.25 738 37.79 ‐0.04 440 64.47 563 59.63 ‐0.07 128 17.04 867 17.54 0.03
(520–623) (36.01–42.97) (627–857) (32.07–43.96) (‐0.2–0.14) (394–494) (58.09–71.81) (456–680) (48.33–71.87) (‐0.25–0.14) (113–145) (15.14–19.33) (633–1147) (14.41–21.44) (‐0.17–0.26)
Israel 0.803 2759 32.41 3480 31.44 ‐0.03 1838 46.97 2277 44.02 ‐0.06 921 19.86 153 20.29 0.02
(2606–2927) (30.62–34.39) (2683–4484) (24.12–40.59) (‐0.26–0.25) (1713–1977) (43.77–50.44) (1720–2947) (33.08–56.83) (‐0.29–0.23) (846–1000) (18.28–21.62) (127–182) (15.57–26.04) (‐0.21–0.31)
Japan 0.87 239 828 83.17 253 321 74.49 ‐0.10 173 940 133.02 178 822 114.78 ‐0.14 65 888 42.00 882 40.36 ‐0.04
(220 045–254 311) (77.37–87.44) (207 167–301 074) (62.1–88.37) (‐0.24–0.06) (160 796–185 273) (124.17–140.89) (142 682–222 462) (91.52–142.05) (‐0.3–0.07) (56 557–72 450) (37.73–45.16) (732–1039) (32.04–49.65) (‐0.21–0.17)
Kuwait 0.851 140 10.05 259 10.32 0.03 100 11.92 181 12.72 0.07 40 6.93 1882 6.63 ‐0.04
(130–149) (9.28–10.72) (216–310) (8.46–12.42) (‐0.15–0.23) (92–107) (10.92–12.79) (139–227) (9.79–15.96) (‐0.17–0.34) (36–44) (6.21–7.7) (1457–2409) (5.22–8.49) (‐0.25–0.21)
Qatar 0.83 83 20.42 153 17.54 ‐0.14 68 23.84 120 18.97 ‐0.20 15 13.06 74 499 13.47 0.03
(67–102) (16.78–24.68) (107–213) (13.23–22.69) (‐0.36–0.14) (52–86) (18.86–29.61) (81–174) (14.08–25.29) (‐0.43–0.09) (12–19) (10.4–16.04) (56 948–92 097) (10.35–16.86) (‐0.19–0.28)
Republic of Korea 0.878 45 010 71.02 68 345 75.66 0.07 31 756 117.33 47 936 118.34 0.01 13 254 37.40 1203 41.95 0.12
(40 638–50 489) (64.09–79.28) (55 468–83 426) (61.36–92.07) (‐0.14–0.31) (27 724–36 550) (102.56–134.48) (37 412–60 031) (92.79–148.38) (‐0.21–0.29) (11 604–15 012) (32.83–42.09) (927–1536) (33.8–50.7) (‐0.09–0.38)
Saudi Arabia 0.805 1156 8.97 1848 9.01 0.00 829 11.46 1239 10.62 ‐0.07 327 5.54 609 6.53 0.18
(1009–1359) (8–10.18) (1411–2305) (7.13–10.91) (‐0.2–0.21) (725–981) (10.24–13.39) (928–1560) (8.17–13.27) (‐0.27–0.15) (279–378) (4.81–6.33) (451–786) (4.9–8.28) (‐0.1–0.48)
Singapore 0.861 3245 65.18 4818 61.39 ‐0.06 2022 88.58 2936 78.05 ‐0.12 1223 46.20 2247 46.90 0.02
(2924–3587) (58.54–72.18) (3741–6168) (48.02–78.24) (‐0.26–0.2) (1770–2314) (77.32–101.94) (2193–3842) (58.72–101.45) (‐0.33–0.14) (1077–1384) (40.58–52.49) (1497–3209) (36.25–59.99) (‐0.21–0.29)
Taiwan (Province of China) 0.868 14 224 46.92 16 026 40.73 ‐0.13 8775 59.88 9654 52.09 ‐0.13 5449 34.84 570 30.87 ‐0.11
(13 443–15 014) (44.32–49.51) (12 395–20 728) (31.55–52.71) (‐0.33–0.12) (8230–9366) (56.15–63.93) (7375–12 486) (39.87–66.95) (‐0.34–0.13) (4995–5896) (31.93–37.68) (382–817) (24–40.24) (‐0.31–0.15)
United Arab Emirates 0.88 260 20.24 627 16.87 ‐0.17 199 22.15 492 19.03 ‐0.14 61 16.86 283 12.51 ‐0.26
(207–314) (16.69–24.01) (454–835) (12.24–23.29) (‐0.36–0.08) (155–246) (17.66–26.99) (349–669) (13.97–26.33) (‐0.32–0.1) (47–75) (13.48–20.84) (233–340) (7.54–18.28) (‐0.54–0.13)
High‐middle SDI
Bahrain 0.751 90 21.50 155 18.01 ‐0.16 64 29.29 109 22.56 ‐0.23 26 13.50 1649 12.83 ‐0.05
(79–101) (19.05–24.08) (117–205) (13.69–22.9) (‐0.34–0.05) (55–74) (25.45–33.36) (79–152) (16.86–29.66) (‐0.42–0.01) (22–30) (11.69–15.61) (1254–2116) (10.19–15.62) (‐0.24–0.15)
Georgia 0.702 1802 32.75 1949 34.83 0.06 1527 63.97 1666 68.25 0.07 275 8.73 7808 8.96 0.03
(1632–1969) (29.65–35.86) (1614–2329) (28.85–41.54) (‐0.14–0.3) (1366–1689) (57.15–70.75) (1371–1996) (56.18–81.57) (‐0.14–0.31) (248–306) (7.86–9.71) (5853–10 343) (7.35–10.77) (‐0.18–0.26)
Jordan 0.731 522 14.97 1015 14.58 ‐0.03 400 22.53 743 20.51 ‐0.09 121 6.87 210 8.08 0.17
(464–584) (13.37–16.75) (836–1233) (12.05–17.57) (‐0.21–0.18) (349–459) (19.73–25.71) (571–943) (15.91–25.81) (‐0.3–0.16) (104–140) (5.9–7.96) (166–264) (6.35–10.25) (‐0.07–0.48)
Kazakhstan 0.723 4019 27.05 4337 23.34 ‐0.14 3298 53.98 3455 44.44 ‐0.18 721 8.37 406 8.47 0.01
(3814–4251) (25.66–28.49) (3676–5019) (19.84–26.85) (‐0.27–0.01) (3096–3536) (50.82–57.63) (2887–4068) (37.5–51.78) (‐0.31–‐0.04) (681–768) (7.92–8.91) (252–594) (7.05–9.98) (‐0.17–0.2)
Lebanon 0.708 1221 28.93 1577 30.40 0.05 815 40.36 920 39.26 ‐0.03 406 18.48 657 23.13 0.25
(1045–1542) (24.76–36.28) (1266–2051) (24.38–39.49) (‐0.12–0.24) (675–1052) (33.56–52.1) (725–1213) (30.94–51.72) (‐0.19–0.16) (336–515) (15.29–23.43) (477–898) (16.79–31.66) (‐0.06–0.56)
Malaysia 0.737 4165 21.04 5544 20.20 ‐0.04 2928 29.58 3896 28.42 ‐0.04 1237 12.60 175 12.05 ‐0.04
(3815–4583) (19.19–23.21) (4258–7066) (15.66–25.69) (‐0.25–0.21) (2660–3246) (26.8–32.81) (2979–4981) (21.78–36.21) (‐0.26–0.22) (1118–1368) (11.37–14.06) (144–213) (9.19–15.3) (‐0.26–0.22)
Oman 0.783 130 11.80 169 9.74 ‐0.17 92 15.11 109 11.68 ‐0.23 38 7.78 315 7.77 0.00
(118–143) (10.72–12.89) (132–224) (7.92–12.01) (‐0.33–0.04) (83–102) (13.61–16.82) (80–160) (9.06–15.5) (‐0.4–0.04) (34–44) (6.74–8.9) (226–432) (5.74–9.33) (‐0.25–0.24)
Sri Lanka 0.69 2170 10.63 2834 10.73 0.01 1604 17.10 1967 16.38 ‐0.04 566 5.22 118 6.09 0.17
(2037–2306) (10–11.3) (2039–3892) (7.78–14.6) (‐0.27–0.37) (1481–1725) (15.81–18.3) (1359–2794) (11.45–23.09) (‐0.33–0.34) (518–619) (4.78–5.71) (90–152) (4.45–8.04) (‐0.15–0.54)
Turkey 0.748 24 613 35.56 31 740 34.95 ‐0.02 20 625 62.65 25 592 59.00 ‐0.06 3988 11.01 76 13.07 0.19
(21 619–27 940) (31.23–40.27) (25 031–39 550) (27.58–43.51) (‐0.24–0.29) (18 045–23 490) (54.81–71.26) (20 163–32 173) (46.56–73.95) (‐0.27–0.24) (3478–4545) (9.61–12.58) (62–92) (10.33–16.36) (‐0.08–0.53)
Middle SDI
Armenia 0.689 1420 38.05 1490 35.13 ‐0.08 1174 72.41 1227 66.05 ‐0.09 246 11.65 6372 11.36 ‐0.03
(1357–1486) (36.45–39.78) (1240–1771) (29.38–41.81) (‐0.23–0.1) (1116–1233) (68.91–76) (1018–1473) (55–79.09) (‐0.24–0.09) (230–263) (10.91–12.43) (4949–8313) (9.34–13.51) (‐0.21–0.17)
Azerbaijan 0.683 1956 24.88 2746 25.34 0.02 1577 43.69 2230 44.41 0.02 379 9.04 3039 9.42 0.04
(1658–2237) (21.13–28.3) (2011–3522) (18.71–32.12) (‐0.18–0.26) (1287–1849) (35.73–51.1) (1504–3000) (30.16–58.78) (‐0.22–0.31) (329–441) (7.78–10.43) (2158–4033) (7.32–12) (‐0.18–0.32)
China 0.686 761 233 49.44 1 137 880 55.13 0.12 534 950 71.85 782 328 79.00 0.10 226 282 28.91 273 33.69 0.17
(693 273–835 137) (45.12–54.12) (950 548–1 344 733) (46.21–64.95) (‐0.09–0.34) (475 301–600 750) (64.16–80.29) (606 195–970 479) (61.77–97.4) (‐0.14–0.41) (200 660–252 832) (25.66–32.31) (193–392) (26.89–41.45) (‐0.08–0.47)
Indonesia 0.66 36 236 20.76 50 234 22.23 0.07 24 946 30.21 34 308 31.89 0.06 11 290 12.27 8375 13.55 0.10
(28 719–42 387) (16.56–24.13) (36 773–62 098) (16.26–27.3) (‐0.13–0.3) (20 103–30 912) (24.77–36.89) (25 370–45 680) (23.94–41.65) (‐0.19–0.36) (6970–16 045) (7.6–17.29) (6254–11 048) (7.59–20.19) (‐0.15–0.42)
Iran (Islamic Republic of) 0.67 5867 10.58 9366 12.53 0.18 4071 14.81 6029 16.26 0.10 1796 6.32 142 8.84 0.40
(5631–6141) (10.1–11.08) (8689–10 053) (11.58–13.47) (0.1–0.27) (3887–4277) (14.06–15.55) (5484–6596) (14.83–17.72) (0.01–0.19) (1704–1898) (5.94–6.68) (110–186) (7.96–9.68) (0.25–0.53)
Iraq 0.671 2546 15.40 4484 18.76 0.22 1883 23.61 3125 27.36 0.16 664 7.54 20 410 10.70 0.42
(1976–3165) (12.07–18.97) (3428–5629) (14.44–23.11) (0–0.48) (1428–2390) (18.02–29.65) (2383–3910) (20.93–33.27) (‐0.06–0.46) (501–862) (5.76–9.73) (16 337–24 713) (8.13–13.75) (0.11–0.84)
Philippines 0.623 10 548 17.23 14 616 17.65 0.02 7667 26.95 10 100 26.23 ‐0.03 2881 8.85 3165 10.34 0.17
(9593–11 828) (15.69–19.3) (11 581–18 202) (14.07–21.88) (‐0.19–0.28) (6777–8908) (23.87–31.2) (7602–13 221) (19.91–34.02) (‐0.3–0.28) (2560–3274) (7.87–10.02) (2280–4193) (7.66–13.54) (‐0.15–0.59)
Syrian Arab Republic 0.619 1303 11.86 1509 11.37 ‐0.04 944 16.54 1052 15.43 ‐0.07 360 6.73 6147 7.14 0.06
(1064–1562) (9.74–14.19) (1100–2011) (8.39–15.01) (‐0.28–0.25) (757–1162) (13.27–20.34) (759–1405) (11.28–20.4) (‐0.32–0.25) (290–436) (5.5–8.03) (4867–7714) (4.89–9.67) (‐0.25–0.41)
Thailand 0.687 19 013 25.39 24 361 23.76 ‐0.06 12 622 36.50 15 986 33.82 ‐0.07 6391 15.94 12 15.19 ‐0.05
(16 557–21 431) (22.19–28.6) (18 211–32 138) (17.79–31.24) (‐0.31–0.26) (10 739–14 550) (31.19–42.01) (11 712–21 314) (24.81–44.92) (‐0.33–0.27) (5578–7259) (13.9–18.15) (8–19) (11.31–20.08) (‐0.31–0.29)
Turkmenistan 0.67 301 9.18 478 10.82 0.18 226 15.40 361 17.86 0.16 75 4.17 1359 5.06 0.21
(285–316) (8.68–9.69) (376–606) (8.57–13.61) (‐0.07–0.49) (211–240) (14.45–16.38) (279–461) (13.98–22.45) (‐0.09–0.47) (68–82) (3.78–4.6) (1018–1763) (3.92–6.45) (‐0.05–0.53)
Uzbekistan 0.631 2079 12.03 3247 13.26 0.10 1510 19.67 2321 21.02 0.07 569 5.95 27 010 7.10 0.19
(1979–2184) (11.48–12.6) (2682–3914) (11.04–15.75) (‐0.08–0.31) (1414–1608) (18.51–20.86) (1882–2825) (17.42–25.08) (‐0.12–0.28) (536–606) (5.6–6.33) (20 873–33 809) (5.9–8.47) (‐0.02–0.44)
Vietnam 0.617 18 774 26.15 28 987 28.89 0.11 13 812 44.07 21 179 47.41 0.08 4962 12.42 458 14.36 0.16
(16 310–21 668) (22.88–30.02) (22 215–37 389) (22.25–36.69) (‐0.12–0.35) (12 031–15 833) (38.94–50.04) (15 882–27 265) (36.26–59.99) (‐0.14–0.33) (4043–6080) (10.18–15.27) (314–632) (10.77–18.76) (‐0.1–0.45)
Low‐middle SDI
Bangladesh 0.483 6760 7.45 9890 7.40 ‐0.01 5531 11.41 7643 11.06 ‐0.03 1229 2.84 7 3.43 0.21
(4985–9276) (5.55–10.1) (6398–15 551) (4.82–11.58) (‐0.27–0.3) (4064–7715) (8.47–15.67) (4841–12 420) (7.05–17.81) (‐0.32–0.3) (857–1743) (1.95–4.01) (6–8) (2.27–4.9) (‐0.07–0.53)
Bhutan 0.455 32 7.01 43 7.58 0.08 24 10.23 31 10.78 0.05 8 3.54 3388 4.23 0.20
(24–42) (5.3–9.16) (31–60) (5.44–10.45) (‐0.1–0.3) (16–33) (6.84–13.92) (20–45) (6.92–15.38) (‐0.13–0.28) (5–13) (2.29–5.85) (2596–4487) (2.82–6.66) (‐0.02–0.5)
Cambodia 0.469 1971 22.25 2962 23.96 0.08 1455 40.19 2137 42.08 0.05 516 9.79 15 925 11.46 0.17
(1633–2416) (18.43–27.5) (2290–3681) (18.86–29.67) (‐0.11–0.28) (1170–1825) (32.6–51.57) (1642–2702) (32.44–53.93) (‐0.14–0.26) (418–635) (8–12.06) (8875–24 064) (8.75–14.68) (‐0.06–0.44)
Democratic People's Republic of Korea 0.558 8127 29.44 9574 29.05 ‐0.01 5595 49.09 6535 46.15 ‐0.06 2532 16.01 47 16.48 0.03
(6172–10 588) (22.51–38.09) (7289–12 305) (22.14–37.09) (‐0.16–0.16) (3941–7719) (35.39–66.33) (4626–8930) (33.51–61.61) (‐0.21–0.12) (1892–3212) (12–20.27) (33–67) (11.68–22.04) (‐0.18–0.27)
India 0.566 60 661 6.82 90 058 7.63 0.12 45 985 10.53 63 048 10.95 0.04 14 676 3.25 4516 4.48 0.38
(55 822–65 774) (6.28–7.4) (73 919–106 987) (6.27–9.05) (‐0.08–0.32) (41 696–50 441) (9.53–11.55) (49 324–78 677) (8.6–13.6) (‐0.19–0.28) (12 940–16 350) (2.85–3.63) (3333–5976) (3.48–5.61) (0.06–0.75)
Kyrgyzstan 0.596 503 13.66 636 12.91 ‐0.05 390 24.23 483 22.29 ‐0.08 112 5.37 136 5.67 0.05
(480–524) (13.04–14.25) (550–726) (11.21–14.63) (‐0.18–0.08) (370–409) (23.06–25.39) (415–552) (19.31–25.41) (‐0.21–0.06) (105–120) (4.98–5.76) (92–181) (4.7–6.72) (‐0.12–0.25)
Lao People's Democratic Republic 0.49 732 21.23 1007 22.00 0.04 549 33.70 734 33.61 0.00 182 9.86 516 11.27 0.14
(557–952) (16.27–27.23) (730–1330) (16.25–28.49) (‐0.16–0.27) (404–737) (25.05–45.08) (525–963) (24.54–43.13) (‐0.2–0.24) (137–258) (7.58–13.9) (396–657) (8.1–16.21) (‐0.09–0.4)
Maldives 0.562 19 9.55 29 9.72 0.02 14 13.80 22 13.78 0.00 4 4.52 925 5.02 0.11
(17–21) (8.55–10.63) (24–35) (7.95–11.65) (‐0.16–0.22) (13–16) (12.08–15.7) (18–27) (11.12–16.7) (‐0.2–0.23) (4–5) (3.89–5.22) (757–1123) (4.03–6.19) (‐0.11–0.38)
Mongolia 0.606 446 28.88 691 29.55 0.02 354 52.33 549 54.16 0.03 92 11.31 263 11.58 0.02
(368–535) (23.89–34.11) (532–911) (23.23–38.17) (‐0.19–0.3) (288–429) (43.3–62.07) (405–733) (40.88–70.52) (‐0.2–0.33) (75–113) (9.3–13.77) (216–312) (9.1–14.83) (‐0.21–0.3)
Myanmar 0.521 8067 21.71 10 552 21.88 0.01 5616 34.02 7165 34.08 0.00 2451 11.87 78 12.56 0.06
(5843–11 322) (15.91–30.39) (7740–14 581) (16.11–29.98) (‐0.18–0.25) (3737–8825) (22.84–53.25) (5031–10 664) (24.19–50.42) (‐0.2–0.26) (1918–3172) (9.29–15.44) (60–101) (9.67–16.55) (‐0.13–0.3)
Palestine 0.588 333 18.77 568 22.43 0.20 259 32.36 435 36.28 0.12 74 7.45 3337 9.88 0.33
(302–365) (17.05–20.53) (481–667) (18.96–26.21) (‐0.01–0.42) (232–287) (29.01–35.86) (368–510) (30.96–42.04) (‐0.08–0.34) (65–85) (6.53–8.49) (3012–3652) (8.01–11.96) (0.04–0.66)
Tajikistan 0.539 529 13.10 665 11.93 ‐0.09 389 19.76 455 17.39 ‐0.12 140 6.65 59 6.96 0.05
(458–611) (11.24–15.21) (532–838) (9.67–14.81) (‐0.28–0.16) (330–455) (16.62–23.22) (358–584) (13.86–22.12) (‐0.32–0.13) (121–163) (5.73–7.73) (43–72) (5.58–8.72) (‐0.18–0.34)
Timor‐Leste 0.514 109 16.46 160 18.82 0.14 79 23.77 113 26.88 0.13 30 9.12 134 10.93 0.20
(77–144) (11.77–21.54) (113–209) (13.4–24.66) (‐0.11–0.44) (51–106) (15.59–31.87) (75–150) (17.96–35.27) (‐0.13–0.45) (22–48) (6.77–14.42) (109–161) (7.71–15.61) (‐0.09–0.55)
Low SDI
Afghanistan 0.343 1112 11.06 1576 11.25 0.02 868 18.75 1170 18.26 ‐0.03 245 4.22 825 5.05 0.20
(610–1900) (6.25–19.01) (895–2505) (6.78–17.88) (‐0.17–0.3) (441–1624) (9.67–35.17) (633–2054) (10.39–31.65) (‐0.21–0.26) (163–360) (2.97–6.03) (626–1063) (3.43–7.12) (‐0.07–0.55)
Nepal 0.422 1184 6.72 1764 7.71 0.15 839 9.64 1194 10.97 0.14 345 3.83 45 4.71 0.23
(862–1570) (4.92–8.88) (1267–2294) (5.53–9.98) (‐0.1–0.43) (613–1115) (7.09–12.76) (856–1545) (7.94–14.04) (‐0.11–0.41) (220–516) (2.42–5.77) (35–56) (3.16–6.76) (‐0.03–0.6)
Pakistan 0.449 15 392 17.22 19 632 16.44 ‐0.05 13 304 28.50 16 467 26.68 ‐0.06 2088 4.82 33 5.43 0.13
(12 086–19 136) (13.56–21.3) (14 826–26 083) (12.48–21.7) (‐0.29–0.3) (10 044–16 978) (21.72–36.19) (11 900–22 596) (19.42–36.34) (‐0.34–0.33) (1631–2574) (3.78–5.88) (24–43) (3.96–7.12) (‐0.17–0.55)
Yemen 0.412 977 9.72 1345 9.57 ‐0.02 776 15.56 1030 15.12 ‐0.03 201 3.81 271 4.18 0.10
(695–1409) (7–14) (909–2008) (6.56–14.22) (‐0.21–0.22) (535–1165) (10.83–23.11) (669–1639) (9.8–23.75) (‐0.24–0.23) (149–274) (2.88–5.11) (210–348) (3.08–5.65) (‐0.2–0.39)

Abbreviations: CI, confidence interval; DALYs, disability‐adjusted life‐years; SDI, sociodemographic index; TBL, tracheal, bronchial and lung.

National comparison

Among Asian countries, 22 countries experienced a decreasing trend in the TBL cancer mortality rate between 2010 and 2019; the greatest increase was detected in Iraq (increase in ASPR = 0.22 [95% CI: 0–0.48]) and the greatest decrease was detected in Oman (decrease in ASPR = −0.17 [95% CI: −0.33–0.04]) (Figure 4).

In 2019, the highest ASPR (per 100 000) of TBL cancer was reported in the Republic of Korea (75.66), Japan (74.49), Singapore (61.39), China (55.13), and Brunei Darussalam (54.57). The lowest ASPR of TBL cancer was reported in Bangladesh (7.4), Bhutan (7.58), India (7.63), Nepal (7.71), and Saudi Arabia (9.01).

In Asian men, the highest ASPR (per 100 000) of TBL cancer was reported among men Republic of Korea (118.34), Japan (114.78), China (79), Singapore (78.05), and Georgia (68.25). The lowest ASPR (per 100 000) of TBL cancer was reported in Saudi Arabia (10.62), Bhutan (10.78), India (10.95), Nepal (10.97), and Bangladesh (11.06).

In women, the highest ASPR (per 100 000) of TBL cancer was reported in Brunei Darussalam (47.91), Singapore (46.9), the Republic of Korea (41.95), Japan (40.36), and China (33.69). The lowest ASPR (per 100 000) of TBL cancer was reported in Bangladesh (3.43), Yemen (4.18), Bhutan (4.23), India (4.48), and Nepal (4.71). Detailed results are presented in Table 6.

Burden of TBL cancer in Asia

Comparison with global data and continents

In Asia, the number of TBL cancer DALYs increased from 21 516 974 (95% CI: 20 162 682–22 913 727) in 2010 to 27 120 537 (95% CI: 23 951 875–30 414 194) in 2019, which is a 1.26‐fold increase. In 2019 more than 59% (27 120 537/45 857 963) of TBL cancer DALYs happened in Asian countries. During this period, the age‐standardized DALYs rate (DALYs ASR) of TBL cancer with a 4% change, decreased from 579.16 (95% CI: 543.52–616.66) per 100 000 in 2010 to 553.68 (95% CI: 488.57–619.78) per 100 000 in 2019, in the same period, this rate globally decreased by 7%, in America by 11%, and in Europe by 510%, Africa by 1% (Figure 1 and Table 1).

In Asian men, the number of TBL cancer DALYs increased from 15 471 795 (95% CI: 14 340 748–16 696 371) in 2010 to 19 032 930 (95% CI: 16 188 395–21 991 610) in 2019, which is over a 1.23‐fold increase. In 2019 approximately 70.2% of TBL cancer DALYs in Asia, occurred in men which included 60.3% (19 032 930/31 582 258) of global male TBL cancer DALYs cases. During this period, the DALYs ASR rate of TBL cancer with a 7% change, decreased from 862.61 (95% CI: 800.85–929.03) per 100 000 in 2010 to 806.43 (95% CI: 688.15–928.33) per 100 000 in 2019, in the same period, this rate globally decreased by 10%, in America by 13%, in Europe by 14%, and Africa by 3% (Table 2).

In Asian women, the number of TBL cancer DALYs increased from 6 045 179 (95% CI: 5 551 988–6 575 776) in 2010 to 8 087 606 (95% CI: 6 962 536–9 358 865) in 2019, which is over a 1.34‐fold increase. In 2019, approximately 29.8% of DALYs related to TBL cancer in Asia were women which included 56.6% (8 087 606/14 275 706) of global female TBL cancer DALYs cases. During this period, the DALYs ASR rate of TBL cancer with a 1% change, increased from 316.95 (95% CI: 290.95–344.55) per 100 000 in 2010 to 321.18 (95% CI: 276.65–371.34) per 100 000 in 2019, while in the same time, this rate globally decreased by 1%, and in American countries decreased by 10%. European countries experienced a stable trend and African countries experienced an increasing trend of 11% (Table 3).

Age distribution

In 2019, age‐specific DALYs cases of TBL cancer peaked at 65–69 years generally, in males, and females. In all age groups, DALYs cases of TBL cancer in males were higher than in females, except in ages above 90 years which in females was higher (Figure 7).

FIGURE 7.

FIGURE 7

Age specific DALYs cases of TBL cancer among sexes in Asia, 2019.

Within Asian regions

In 2019, the highest DALYs ASR of TBL was observed in East Asian countries (825.81 [95% CI: 696.85–969.46]); with a 5% decrease compared with 2010. Southeast Asian countries experienced a stable trend and South Asian countries experienced an increasing trend of 5%; other Asian countries experienced a decreasing trend from 2010 to 2019 (by 1%–14%) (Figure 3 and Table 1).

In men, the highest DALYs ASR of TBL was observed in East Asian countries (1195.54 [95% CI: 949.99–1478.03]); with a 6% decrease compared with 2010. Also, other Asian countries experienced a decreasing trend from 2010 to 2019 (by 1%–18%). High‐income Asia Pacific countries experienced the highest decrease (Table 2).

In women, the highest DALYs ASR of TBL was observed in East Asian countries (489.73 [95% CI: 396.14–597.18]); with a 2% decrease compared with 2010. Also, high‐income Asia Pacific countries experienced a decreasing trend from 2010 to 2019 by 7%. Other Asian countries experienced an increasing trend from 2010 to 2019 (by 1%–30%). South Asian countries experienced the highest decrease (Table 3).

Based on SDI

In 2019, among high SDI Asian countries, Brunei Darussalam (867.69) and Taiwan (Province of China) (638.74) had the highest DALYs ASR of TBL, and Saudi Arabia (208.01) had the lowest rate. Among high‐middle SDI Asian countries, Georgia (828.59) and Turkey (814.58) had the highest DALYs ASR of TBL, and Oman (211.73) had the lowest rate. In middle SDI Asian countries, China (831.27) and Armenia (772.08) had the highest DALYs ASR of TBL, and Turkmenistan (265.85) had the lowest rate. Among low‐middle SDI Asian countries, Mongolia (727.67) and the Democratic People's Republic of Korea (712.30) had the highest ASPR of TBL, and Bangladesh (181.71) had the lowest rate.

Among low SDI Asian countries, Pakistan (425.72) had the highest DALYs ASR of TBL, and Nepal (195.08) had the lowest rate. More details are presented in Table 7.

TABLE 7.

The DALYs of TBL cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Both Male
2010 2019 % change 2010–2010 2010 2019 % change 2010‐2019
Location SDI 2019 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000 Number ASR per 100 000
lower (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
High SDI
Brunei Darussalam 0.823 1736 881.93 2578 867.69 ‐0.02 964 1117.64 1402 1086.94 ‐0.03
(1579–1914) (806.29–967.48) (2268–2923) (768.53–975.37) (‐0.14–0.13) (852–1089) (990.1–1251.24) (1163–1666) (917.83–1259.12) (‐0.19–0.15)
Cyprus 0.841 7851 543.85 9677 496.50 ‐0.09 6146 905.87 7498 796.91 ‐0.12
(7365–8373) (511.28–580.29) (8511–10 948) (437.29–562.21) (‐0.2–0.03) (5717–6629) (844.61–975.76) (6527–8559) (695.12–911.42) (‐0.24–0.01)
Israel 0.803 45 045 530.55 52 637 478.11 ‐0.10 30 992 792.34 35 769 694.47 ‐0.12
(43 220–46 601) (509.75–548.41) (49 095–55 907) (446.69–507.47) (‐0.16–‐0.04) (29 743–32 194) (761.06–823.47) (33 302–38 347) (646.72–745.22) (‐0.18–‐0.06)
Japan 0.87 1 354 942 475.84 1 347 365 408.04 ‐0.14 1 005 355 778.59 966 169 638.55 ‐0.18
(1 244 988–1 409 971) (445.3–491.42) (1 211 168–1 426 790) (378.67–427.43) (‐0.17–‐0.12) (945 825–1 037 352) (737.05–801.79) (890 896–1 017 886) (595.3–669.43) (‐0.21–‐0.15)
Kuwait 0.851 3187 221.34 5541 214.80 ‐0.03 2429 278.57 4263 287.61 0.03
(2983–3386) (205.84–235.27) (4539–6683) (174.68–260.68) (‐0.21–0.18) (2244–2610) (257.37–298.19) (3277–5348) (222.72–360.28) (‐0.19–0.3)
Qatar 0.83 2037 457.40 3497 373.88 ‐0.13 1742 555.43 2925 426.90 ‐0.23
(1638–2534) (373.58–556.09) (2442–4860) (279.21–491.27) (‐0.2–‐0.05) (1339–2214) (440.05–691.03) (1985–4180) (315.74–572.97) (‐0.45–0.06)
Republic of Korea 0.878 363 214 572.49 448 177 498.37 ‐0.05 270 501 989.99 329 780 812.08 ‐0.18
(345 908–385 465) (543.45–608.08) (407 150–489 987) (452.28–545.03) (‐0.24–0.15) (258 260–289 258) (942.81–1057.22) (295 922–365 420) (726.93–896.9) (‐0.26–‐0.09)
Saudi Arabia 0.805 30 004 219.72 45 488 208.01 ‐0.06 22 272 288.97 32 838 260.49 ‐0.10
(26 190–34 824) (196.73–251.56) (34 469–57 172) (162.62–253.25) (‐0.32–0.27) (19 367–26 307) (258.76–338.48) (24 493–41 864) (199.92–324.97) (‐0.29–0.12)
Singapore 0.861 25 678 508.08 32 008 406.24 ‐0.05 17 179 732.85 20 883 549.33 ‐0.25
(24 501–26 642) (481.56–527.39) (29 533–34 271) (373.24–435.04) (‐0.29–0.24) (16 388–17 912) (694.31–763.13) (19 024–22 407) (499.22–590.64) (‐0.32–‐0.19)
Taiwan (Province of China) 0.868 201 116 663.19 250 042 638.74 ‐0.11 130 642 889.24 156 142 847.27 ‐0.05
(191 569–208 015) (630.62–686.06) (195 264–323 024) (500.04–824.72) (‐0.35–0.2) (124 689–135 612) (847.68–923.17) (122 385–204 204) (665.16–1101.66) (‐0.26–0.24)
United Arab Emirates 0.88 7069 491.67 16 698 406.46 0.07 5564 549.42 13 406 468.70 ‐0.15
(5634–8636) (404.44–584.94) (12 066–22 166) (295.09–559.14) (‐0.11–0.27) (4352–6903) (438.29–669.67) (9528–18 308) (343.4–645.66) (‐0.33–0.09)
High‐middle SDI
Bahrain 0.751 2162 485.53 3546 392.08 ‐0.19 1618 687.65 2677 518.94 ‐0.25
(1898–2450) (429.2–542.66) (2675–4751) (294.96–503.78) (‐0.37–0.02) (1383–1865) (596.79–783.11) (1931–3710) (386.88–684.76) (‐0.43–‐0.01)
Georgia 0.702 43 531 797.62 45 743 828.59 0.04 37 079 1556.10 39 358 1623.55 0.04
(39 541–47 494) (724.62–872.98) (37 925–54 188) (684.05–980.38) (‐0.16–0.26) (33 184–40 916) (1385.03–1718.34) (32 601–46 938) (1343.63–1925.24) (‐0.16–0.28)
Jordan 0.731 12 952 360.35 24 231 338.02 ‐0.06 10 217 556.96 18 653 497.83 ‐0.11
(11 485–14 706) (321.08–405.56) (19 817–29 413) (276.61–409.77) (‐0.25–0.14) (8916–11 730) (488.61–636.3) (14 277–23 721) (385.83–628.29) (‐0.32–0.14)
Kazakhstan 0.723 100 157 667.21 99 098 529.99 ‐0.21 82 595 1331.23 79 489 1011.22 ‐0.24
(95 150–105 761) (633.87–703.56) (84 119–114 547) (452.01–608.74) (‐0.33–‐0.07) (77 609–88 472) (1252.99–1420.47) (66 646–93 305) (856.32–1179.95) (‐0.36–‐0.11)
Lebanon 0.708 27 614 653.49 32 712 629.57 ‐0.04 19 893 985.74 21 762 926.00 ‐0.06
(23 464–34 891) (555.91–825.18) (26 403–42 585) (507.29–817.1) (‐0.19–0.13) (16 580–25 367) (824.21–1255.03) (17 023–28 494) (725.13–1215.38) (‐0.21–0.11)
Malaysia 0.737 99 296 492.31 125 454 452.95 ‐0.08 70 051 694.58 88 682 640.66 ‐0.08
(91 031–108 913) (449.62–541.33) (95 772–158 721) (349.01–573.29) (‐0.29–0.16) (63 605–77 170) (630.74–767.54) (67 490–113 258) (490.41–816.72) (‐0.29–0.17)
Oman 0.783 3145 275.24 3876 211.73 ‐0.06 2343 369.58 2755 274.30 ‐0.26
(2856–3450) (250.81–302.08) (3002–5245) (170.66–267.77) (‐0.3–0.27) (2108–2612) (332.63–411.06) (2018–4078) (211.84–366.38) (‐0.42–0.01)
Sri Lanka 0.69 50 700 246.24 61 125 231.39 ‐0.04 37 667 397.26 42 870 355.96 ‐0.10
(47 614–53 917) (231.9–261.63) (44 055–83 501) (167.54–315.61) (‐0.25–0.24) (34 739–40 500) (368.42–425.46) (29 685–60 571) (248.38–498.89) (‐0.37–0.25)
Turkey 0.748 606 723 868.40 743 637 814.58 0.15 521 564 1564.61 625 682 1431.86 ‐0.08
(535 329–685 649) (766.16–982.9) (585 408–929 199) (643.77–1017) (‐0.1–0.45) (455 485–593 194) (1372.32–1780.42) (493 490–787 341) (1132.21–1796.08) (‐0.3–0.2)
Middle SID
Armenia 0.689 32 931 881.64 32 530 772.08 ‐0.12 27 383 1679.98 26 989 1456.82 ‐0.13
(31 610–34 420) (847.73–919.95) (27 097–38 700) (644.04–919.53) (‐0.27–0.05) (26 166–28 753) (1607.69–1765.83) (22 437–32 354) (1215.4–1753.28) (‐0.28–0.04)
Azerbaijan 0.683 50 528 627.24 67 384 615.53 ‐0.02 40 885 1103.50 55 020 1083.21 ‐0.02
(42 848–57 711) (531.96–712.77) (49 096–86 484) (453.49–778.51) (‐0.21–0.21) (33 344–47 893) (905.06–1286.31) (37 056–73 911) (739–1437.01) (‐0.25–0.27)
China 0.686 13 706 787 878.34 17 128 584 831.27 ‐0.05 9 750 174 1285.67 11 967 767 1203.78 ‐0.06
(12 490 817–14 986 265) (802.07–956.93) (14 340 491–20 231 342) (699.11–979.99) (‐0.22–0.14) (8 652 617–10 933 563) (1148.32–1434.13) (9 374 367–14 952 335) (950.19–1495.1) (‐0.27–0.19)
Indonesia 0.66 951 020 531.75 1 279 981 555.79 0.05 652 011 771.88 872 361 795.96 0.03
(768 970–1 118 598) (432.67–622.97) (927 626–1 596 040) (404.21–685.35) (‐0.15–0.26) (522 694–808 743) (627.82–940.17) (632 434–1 170 979) (584.55–1045.61) (‐0.21–0.33)
Iran (Islamic Republic of) 0.67 145 184 255.72 218 990 286.82 0.12 104 036 369.43 150 337 396.94 0.07
(139 547–151 340) (244.38–266.88) (203 461–234 523) (266.09–307.6) (0.05–0.2) (99 266–108 916) (351.11–387.4) (137 471–164 431) (364.05–434.82) (‐0.01–0.17)
Iraq 0.671 66 028 388.14 110 712 451.59 0.16 49 430 600.79 79 463 675.57 0.12
(51 003–82 497) (303.02–480.89) (84 178–139 887) (346.04–557.52) (‐0.05–0.42) (37 525–62 971) (458.88–759.13) (60 517–100 726) (516.66–825.13) (‐0.09–0.41)
Philippines 0.623 274 077 438.06 373 177 443.59 ‐0.18 201 099 684.08 258 071 658.20 ‐0.04
(249 033–307 840) (398.81–491.29) (300 745–458 874) (359.55–543.86) (‐0.39–0.08) (176 964–228 943) (609.27–784.78) (194 607–334 686) (499.78–848.85) (‐0.28–0.25)
Syrian Arab Republic 0.619 32 840 289.91 36 951 274.37 ‐0.10 24 536 418.24 26 803 389.30 ‐0.07
(26 864–39 516) (236.81–347.76) (26 937–49 538) (202.98–363.54) (‐0.3–0.14) (19 591–30 237) (335.64–513.89) (19 320–36 087) (283.36–517.06) (‐0.32–0.25)
Thailand 0.687 437 879 575.84 524 356 512.94 0.14 292 638 830.38 348 203 735.77 ‐0.11
(381 744–495 015) (503.63–649.94) (389 891–698 681) (382.75–681.94) (‐0.11–0.45) (249 564–336 188) (709.5–953.68) (253 961–465 752) (538.38–977.94) (‐0.36–0.22)
Turkmenistan 0.67 7793 232.03 11 915 265.85 ‐0.17 5868 387.83 9035 438.57 0.13
(7379–8188) (220.21–244.35) (9357–15 098) (209.71–336.07) (‐0.36–0.07) (5479–6243) (363.74–411.91) (7009–11 546) (343.74–552.56) (‐0.12–0.44)
Uzbekistan 0.631 53 638 300.38 80 570 320.85 0.05 38 995 490.90 57 824 510.33 0.04
(51 091–56 334) (286.41–314.34) (66 295–96 841) (266.53–380.72) (‐0.16–0.28) (36 607–41 509) (462.79–520.87) (47 028–70 213) (421.64–610.42) (‐0.15–0.26)
Vietnam 0.617 468 294 639.58 676 894 668.83 ‐0.20 347 144 1079.86 498 965 1102.40 0.02
(40 6280–541 940) (557.93–736.21) (514 966–873 765) (512.02–853.16) (‐0.25–‐0.15) (300 374–398 441) (950.74–1229.85) (374 943–644 026) (837.95–1402.61) (‐0.19–0.26)
Low‐middle SDI
Bangladesh 0.483 175 070 188.69 245 789 181.71 ‐0.04 142 318 288.19 188 736 271.23 ‐0.06
(128 455–241 803) (139.99–257.39) (158 426–385 218) (117.75–284.34) (‐0.29–0.26) (103 834–198 827) (212.87–398.06) (119 496–309 965) (172.15–441.53) (‐0.34–0.26)
Bhutan 0.455 814 175.54 1072 184.25 0.05 612 254.70 774 261.11 0.03
(615–1067) (132.78–230.05) (764–1474) (132.46–253.15) (‐0.13–0.27) (416–836) (171.66–346.08) (504–1094) (167.93–370.95) (‐0.16–0.24)
Cambodia 0.469 52 251 579.09 76 026 606.82 0.05 38 540 1042.53 54 880 1062.37 0.02
(43 259–63 797) (482.12–712.77) (58 767–94 334) (473.95–750.69) (‐0.14–0.25) (30 944–48 299) (846.07–1334.54) (42 147–69 438) (817.66–1358.8) (‐0.17–0.23)
Democratic People's Republic of Korea 0.558 205 141 735.45 235 437 712.30 ‐0.03 141 800 1220.58 161 707 1126.86 ‐0.08
(15 4525–270 707) (556.37–962.31) (177 717–306 193) (539.32–920.19) (‐0.18–0.15) (99 397–197 104) (876.92–1666.88) (113 816–221 451) (815.69–1514.4) (‐0.22–0.1)
India 0.566 1 584 205 174.72 2 275 225 190.16 0.09 1 196 732 268.48 1 586 070 271.30 0.01
(1 461 551–1 723 380) (161.5–190.55) (1 871 750–2 691 295) (156.64–224.66) (‐0.1–0.28) (1 083 500–1 322 202) (242.68–296.34) (1 233 846–1 950 175) (211.91–331.81) (‐0.21–0.26)
Kyrgyzstan 0.596 12 824 341.57 15 377 308.12 ‐0.10 9999 606.25 11 721 532.34 ‐0.12
(12 251–13 377) (326.42–356.36) (13 279–17 539) (266.83–350.84) (‐0.22–0.03) (9501–10 474) (576.85–634.81) (10 038–13 425) (460.12–608.84) (‐0.25–0.01)
Lao People's Democratic Republic 0.49 19 739 559.56 26 518 566.50 0.01 14 738 883.09 19 216 861.29 ‐0.02
(14 969–25 758) (428.19–720.42) (19 142–35 092) (418.1–736.93) (‐0.18–0.24) (10 766–19 870) (657.67–1187.77) (13 684–25 262) (624.09–1112.8) (‐0.22–0.21)
Maldives 0.562 416 208.86 620 199.38 ‐0.05 322 302.61 478 283.47 ‐0.06
(373–462) (186.77–232.2) (511–742) (163.94–237.7) (‐0.22–0.15) (283–365) (266.27–343.46) (389–577) (229.69–342) (‐0.25–0.14)
Mongolia 0.606 11 716 732.13 17 529 727.67 ‐0.03 9349 1325.52 14 013 1335.28 0.01
(9652–14 055) (605.83–866.62) (13 389–23 176) (568.02–941.27) (‐0.2–0.21) (7605–11 305) (1092.98–1580.67) (10 355–18 720) (1008.65–1737.42) (‐0.22–0.3)
Myanmar 0.521 216 064 570.40 271 546 556.09 0.13 150 353 892.47 184 512 864.98 ‐0.03
(156 726–309 983) (419.32–806.31) (199 769–374 583) (409.15–761.85) (‐0.12–0.41) (99 360–240 211) (598.49–1412.17) (129 789–274 994) (613.93–1280.98) (‐0.22–0.23)
Palestine 0.588 8584 469.81 14 203 546.36 0.01 6760 814.71 11 162 901.55 0.11
(7778–9410) (426.36–513.68) (12 043–16 667) (462.77–639.36) (‐0.19–0.24) (6054–7507) (731.68–903.57) (9466–13 136) (768.02–1046.3) (‐0.09–0.33)
Tajikistan 0.539 14 017 335.26 17 302 300.28 ‐0.01 10 326 505.89 11 831 436.74 ‐0.14
(12 126–16 132) (288.52–387.58) (13 763–21 772) (243.87–374.01) (‐0.22–0.27) (8779–12 028) (428.03–593.24) (9318–15 154) (347–555.17) (‐0.34–0.11)
Timor‐Leste 0.514 2822 421.11 4104 479.52 ‐0.06 2027 606.06 2894 682.80 0.13
(1958–3735) (297.78–553.99) (2888–5397) (341.33–629.51) (‐0.27–0.23) (1311–2748) (395.2–815.78) (1898–3902) (456.42–904.17) (‐0.13–0.45)
Low SDI
Afghanistan 0.343 31 563 299.90 44 553 302.57 0.01 24 344 504.01 32 821 485.96 ‐0.04
(17 036–53 762) (167.68–511.88) (25 083–71 319) (179.92–481.25) (‐0.18–0.3) (12 063–45 437) (257.6–947.67) (17 512–57 862) (274.05–844.56) (‐0.21–0.25)
Nepal 0.422 30 976 172.98 45 196 195.08 ‐0.23 21 828 247.11 30 434 277.16 0.12
(22 476–41 114) (126.4–228.16) (32 343–59 231) (139.51–253.47) (‐0.38–0) (15 924–29 084) (181.42–327.39) (21 678–39 516) (198.22–357.17) (‐0.13–0.39)
Pakistan 0.449 416 861 453.80 522 648 425.72 0.16 359 222 749.59 436 968 689.89 ‐0.08
(321 808–524 148) (350.78–567.63) (400 317–680 663) (327.1–550.78) (‐0.04–0.38) (267 008–467 611) (559.17–968.14) (318 323–591 600) (504.54–928) (‐0.35–0.3)
Yemen 0.412 26 197 253.64 36 208 248.83 ‐0.02 20 790 405.89 27 748 393.94 ‐0.03
(18 556–37 800) (182.15–366.57) (24 430–53 799) (169.31–368.91) (‐0.21–0.22) (14 324–31 221) (281.88–605.7) (17 997–44 272) (254.61–622.7) (‐0.24–0.22)
Female
2010 2019 % change 2010–2019
Location SDI 2019 Number ASR per 100 000 Number ASR per 100 000
lower (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
High SDI
Brunei Darussalam 0.823 772 706.37 1176 730.80 0.03
(688–860) (632.31–784.18) (980–1385) (618.67–850.63) (‐0.13–0.21)
Cyprus 0.841 1705 227.50 2178 219.18 ‐0.04
(1557–1871) (208.32–250.03) (1844–2524) (186.62–253.94) (‐0.19–0.12)
Israel 0.803 14 052 304.03 16 867 285.32 ‐0.06
(13 208–14 792) (286.9–319.84) (15 241–18 355) (258.62–310.37) (‐0.14–0.03)
Japan 0.87 349 587 225.99 381 197 210.56 ‐0.07
(300 800–376 526) (203.81–238.07) (315 576–418 629) (186.69–225.92) (‐0.11–‐0.03)
Kuwait 0.851 758 125.97 1278 104.23 ‐0.17
(688–827) (113.8–137.54) (989–1618) (82.26–130.24) (‐0.34–0.03)
Qatar 0.83 295 241.22 572 220.52 ‐0.09
(233–366) (193.55–293.68) (421–734) (170.71–275.17) (‐0.27–0.13)
Republic of Korea 0.878 92 714 263.26 118 396 245.25 ‐0.07
(85 603–98 182) (242.92–278.73) (104 054–131 119) (216.78–270.42) (‐0.15–0.02)
Saudi Arabia 0.805 7733 123.21 12 650 127.19 0.03
(6645–8978) (107.08–140.84) (9344–16 468) (95.79–162.81) (‐0.2–0.31)
Singapore 0.861 8499 318.79 11 125 277.03 ‐0.13
(7891–9022) (295.34–338.85) (9748–12 390) (242.91–308.51) (‐0.22–‐0.04)
Taiwan (Province of China) 0.868 70 474 451.64 93 900 457.18 0.01
(65 968–73 910) (421.7–473.69) (73 474–120 865) (355.86–591.97) (‐0.21–0.31)
United Arab Emirates 0.88 1505 383.78 3292 274.87 ‐0.28
(1167–1859) (305.93–468.78) (2254–4366) (164.71–396.5) (‐0.54–0.08)
High‐middle SDI
Bahrain 0.751 544 272.77 869 238.46 ‐0.13
(472–629) (237.79–315.2) (682–1070) (189.98–289.87) (‐0.3–0.06)
Georgia 0.702 6452 208.47 6385 207.18 ‐0.01
(5824–7120) (187.61–230.63) (5261–7673) (170.33–250.11) (‐0.2–0.23)
Jordan 0.731 2735 149.93 5578 161.92 0.08
(2345–3161) (128.73–173.63) (4366–7137) (128.25–205.65) (‐0.15–0.37)
Kazakhstan 0.723 17 562 202.47 19 608 187.71 ‐0.07
(16 578–18 646) (191.3–214.83) (16 256–23 097) (156.51–220.87) (‐0.24–0.1)
Lebanon 0.708 7722 350.95 10 949 384.97 0.10
(6511–9720) (296.83–442.46) (8038–14 776) (281.37–520.49) (‐0.16–0.34)
Malaysia 0.737 29 244 291.69 36 772 266.48 ‐0.09
(26 440–32 255) (263.54–322.87) (28 061–47 106) (203.45–339.35) (‐0.29–0.16)
Oman 0.783 803 157.82 1121 141.83 ‐0.10
(704–913) (137.42–180.41) (800–1377) (104.09–169.59) (‐0.33–0.12)
Sri Lanka 0.69 13 033 119.16 18 254 128.58 0.08
(11 992–14 229) (109.67–129.9) (13 292–24 267) (94.22–170.76) (‐0.21–0.43)
Turkey 0.748 85 158 233.33 117 955 250.26 0.07
(74 588–96 867) (204.61–265.97) (93 375–146 975) (198.42–311.87) (‐0.17–0.4)
Middle SID
Armenia 0.689 5548 263.73 5540 242.58 ‐0.08
(5221–5921) (247.62–281.46) (4557–6581) (198.59–288.26) (‐0.25–0.11)
Azerbaijan 0.683 9643 223.93 12 364 222.46 ‐0.01
(8400–11 193) (194.18–258.94) (9432–15 634) (172.67–281.07) (‐0.22–0.26)
China 0.686 3 956 613 500.77 5 160 817 492.17 ‐0.02
(3 524 734–4 404 296) (444.94–556.06) (4 138 835–6 353 139) (393.74–604.27) (‐0.23–0.23)
Indonesia 0.66 299 009 315.66 407 620 339.17 0.07
(182 599–424 669) (194.98–443.91) (226 898–623 490) (189.97–516.37) (‐0.17–0.39)
Iran (Islamic Republic of) 0.67 41 148 141.32 68 653 178.15 0.26
(39 261–43 163) (134.22–148.3) (62 555–74 042) (161.41–192.43) (0.13–0.37)
Iraq 0.671 16 598 183.06 31 249 239.59 0.31
(12 447–21 665) (138.93–236.13) (23 269–41 007) (181.03–307.77) (0.02–0.7)
Philippines 0.623 74 977 224.83 115 106 259.58 0.15
(66 626–84 617) (200.27–253.9) (86 753–150 100) (197.49–336.23) (‐0.15–0.55)
Syrian Arab Republic 0.619 8304 149.22 10 148 155.27 0.04
(6706–10 155) (121.78–178.86) (6956–13 953) (106.32–210.2) (‐0.25–0.4)
Thailand 0.687 145 242 357.80 176 154 321.69 ‐0.10
(126 649–165 290) (312.22–406.92) (131 468–234 593) (238.79–427.89) (‐0.36–0.21)
Turkmenistan 0.67 1925 104.73 2880 122.63 0.17
(1737–2120) (94.93–115.65) (2203–3719) (94.53–158.09) (‐0.09–0.48)
Uzbekistan 0.631 14 642 147.49 22 746 169.49 0.15
(13 757–15 641) (139.11–156.73) (18 516–27 581) (140.38–203.1) (‐0.06–0.39)
Vietnam 0.617 121 151 298.72 177 929 325.27 0.09
(98 246–148 007) (243.31–366.61) (133 317–235 275) (245.25–426.63) (‐0.15–0.37)
Low‐middle SDI
Bangladesh 0.483 32 752 73.08 57 053 85.35 0.17
(22 955–46 303) (50.63–103.78) (38 132–81 434) (56.79–121.16) (‐0.11–0.48)
Bhutan 0.455 202 89.76 297 103.59 0.15
(130–335) (58.16–148.43) (194–475) (68.51–165.05) (‐0.06–0.45)
Cambodia 0.469 13 712 255.02 21 146 290.69 0.14
(11 060–16 856) (208.3–313.1) (16 089–27 193) (222–372.55) (‐0.08–0.4)
Democratic People's Republic of Korea 0.558 63 341 399.33 73 730 403.09 0.01
(46 751–80 830) (295.05–507.97) (52 217–98 877) (281.86–545.06) (‐0.2–0.25)
India 0.566 387 473 83.99 689 155 112.92 0.34
(337 962–432 534) (73.01–93.81) (533 934–873 541) (87.71–142.75) (0.02–0.71)
Kyrgyzstan 0.596 2825 132.57 3656 133.43 0.01
(2631–3014) (123.23–141.85) (3012–4338) (110.79–157.91) (‐0.17–0.19)
Lao People's Democratic Republic 0.49 5000 262.98 7302 292.87 0.11
(3744–7061) (200.26–370.62) (5148–10 478) (208.9–416.89) (‐0.11–0.37)
Maldives 0.562 94 98.29 142 101.31 0.03
(81–107) (84.75–112.82) (114–174) (81.22–123.74) (‐0.17–0.28)
Mongolia 0.606 2366 279.40 3517 277.36 ‐0.01
(1928–2906) (228.98–340.45) (2711–4617) (216.31–357.36) (‐0.23–0.26)
Myanmar 0.521 65 711 311.66 87 034 318.70 0.02
(51 120–84 000) (241.54–396.25) (66 622–115 527) (245.68–419.49) (‐0.17–0.26)
Palestine 0.588 1824 178.40 3042 219.65 0.23
(1606–2076) (156.62–203.01) (2491–3666) (178.84–265.01) (‐0.03–0.54)
Tajikistan 0.539 3691 169.53 5470 175.30 0.03
(3184–4273) (146.33–196.93) (4327–6888) (141.02–219.76) (‐0.19–0.33)
Timor‐Leste 0.514 795 235.30 1210 280.22 0.19
(566–1252) (171.45–374.02) (840–1736) (196.83–400.22) (‐0.1–0.54)
Low SDI
Afghanistan 0.343 7220 118.35 11 732 139.69 0.18
(4658–10 796) (81.42–170.34) (7195–17 414) (92.77–198.61) (‐0.09–0.51)
Nepal 0.422 9148 99.40 14 762 119.79 0.21
(5909–13 668) (62.82–149.13) (9894–21 002) (80.4–171.49) (‐0.06–0.57)
Pakistan 0.449 57 638 128.42 85 679 141.81 0.10
(45 789–71 940) (102.3–158.25) (62 126–114 158) (104.07–189.04) (‐0.18–0.51)
Yemen 0.412 5407 98.81 8460 107.43 0.09
(3996–7443) (74.26–132.27) (5985–11 599) (78.67–145.39) (‐0.2–0.38)

Abbreviations: CI, confidence interval; DALYs, disability‐adjusted life‐years; SDI, sociodemographic index; TBL, tracheal, bronchial and lung.

National comparison

Among Asian countries, 33 countries experienced a decreasing trend in the TBL cancer DALYs ASR between 2010 and 2019; the greatest increase was detected in Iraq (increase in DALYs ASR = 0.16 [95% CI: −0.05–0.42]) and the greatest decrease was detected in Oman (decrease in DALYs ASR = −0.23 [95% CI: −0.38–0]) (Figure 4).

In 2019, the highest DALYs ASR (per 100 000) of TBL cancer was reported in Brunei Darussalam (867.69), China (831.27), Georgia (828.59), Turkey (814.58), and Armenia (772.08). The lowest DALYs ASR of TBL cancer was reported in Bangladesh (181.71), Bhutan (184.25), India (190.16), Nepal (195.08), and Maldives (199.38).

In Asian men, the highest DALYs ASR (per 100 000) of TBL cancer was reported in Georgia (1623.55), Armenia (1456.82), Turkey (1431.86), Mongolia (1335.28), and China (1203.78). The lowest DALYs ASR (per 100 000) of TBL cancer was reported in Saudi Arabia (260.49), Bhutan (261.11), Bangladesh (271.23), India (271.3), and Oman (274.3).

In women, the highest DALYs ASR (per 100 000) of TBL cancer was reported in Brunei Darussalam (730.8), China (492.17), Taiwan (Province of China) (457.18), Democratic People's Republic of Korea (403.09), and Lebanon (384.97). The lowest DALYs ASR (per 100 000) of TBL cancer was reported in Bangladesh (85.35), Maldives (101.31), Bhutan (103.59), Kuwait (104.23), and Yemen (107.43). Detailed results are presented in Table 7.

DISCUSSION

In this study, temporal trends of TBL cancer were estimated in 49 Asian countries and territories by geographical region and SDI and compared with the global data between 2010 and 2019. This study is the first in which calculated temporal trends of TBL cancer were estimated in Asian countries. The results showed that from 2010 to 2019 in the total population there was an over 1.34‐fold increase in the number of TBL cancer incidences. Also, ASIR, ASDR, and ASPR decreased while the age‐standardized DALY rate increased.

In 2019, more than half of TBL cancer cases (58%) occurred in Asian countries. However, during this period, the ASIR of TBL decreased by 1%. Also, the results of the study show that the number of TBL cancer increased more in women than in men so the number of TBL cancer cases in men increased 1.3‐fold and in women 1.42‐fold from 2010 to 2019. In men, the age group of 65–69 years had the higher number of TBL cancer, while in women, this number was greater in the age group of 70–74 years. Also, the ASIR decreased in men by 3% but in women increased by 5%.

In this period, ASIR decreased globally, in America and Europe in men but this index increased globally, in Europe, and Africa, and decreased in America in women.

The main risk factor is tobacco smoking; however, genetic sensitivity, unhealthy eating, occupational exposure, air pollution, chronic bronchitis, emphysema, tuberculosis, pneumonia, asthma, and environmental carcinogens (arsenic, asbestos, and radon) are other risk factors that can act independently, or together, with smoking. 30 , 31 Another study in Europe showed that lung cancer rates were increasing in female smokers but decreasing in male smokers over time. 32 Other studies reported that women who are heavy smokers had a higher risk of lung cancer than men. 33 , 34 It has also been found that sex hormones can be associated with lung cancer. 35 However, gender differences are important and must be considered. For lung cancer, behavioral factors such as smoking and gender‐related factors such as genetic susceptibility, exposure to sex hormones and molecular characteristics may increase a woman's susceptibility. 36 , 37 , 38

One of the modifiable risk factors is cigarette smoking and quitting smoking can reduce the risk of lung cancer by up to 50% in 10 years. 39 Because TBL cancer risk factors have various distributions in different geographical areas, for the prevention of TBL cancer, first we must not only know the geographic and temporal patterns of lung cancer incidence and mortality but also the risk factors. Research on the risk factors must be done in different areas to focus intervention programs on dominant and important risk factors in each area. Since smoking is the most important risk factor for lung cancer, for effective prevention and management of lung cancer, the determination of the risk factors in smokers and nonsmokers should be a useful action. On the other hand, education, tax increase, and government legislation, such as prohibiting smoking and introducing packaging for cigarettes, can achieve better outcomes. 40

In 2019, the highest ASIR (per 100 000) of TBL cancer was reported in Brunei Darussalam, China, the Republic of Korea, Turkey, and Taiwan. The lowest ASIR of TBL cancer was reported in Bangladesh, India, Bhutan, Nepal, and Saudi Arabia. Deng et al. showed that the incident cases, deaths, and DALYs of TBL cancer in China growth ranged from 140% to 240%. 41

According to the results in men and women, the highest number of TBL cancer deaths was in the age group of 70 to 74 years. The results of the study also showed that the number of TBL cancer deaths was higher in men than in women (1.28‐fold vs. 1.4‐fold). However, ASDR of TBL cancer in women increased by 2% but decreased in men by 6% from 2010 to 2019. Also in 2019, ASDR of TBL cancer in men was higher than in women. In the meantime, ASDR decreased globally, in America and Europe in men while this index was globally stable in women, but increased in Europe and Africa, and decreased in America. Zang et al. showed that at all levels of cigarette smoke exposure, women are consistently at a greater risk for developing major types of lung cancer than men. 42 This difference between men and women is probably due to the greater susceptibility of women to tobacco carcinogens. 43 Other studies in developed countries consistent with this study showed that lung cancer mortality has increased rapidly in women, while it has remained constant or decreased in men. 44 , 45 It should be noted that the risks and pathophysiology of lung cancer in nonsmoker women are different compared to nonsmoker men. In Asia, 60%–80% of women with lung cancer have never smoked, while 10%–15% of men with lung cancer have never smoked. 46 , 47

In this study, the prevalence of TBL cancer was also assessed. According to the results, from 2010 to 2019 the prevalence of TBL cancer increased in men by 1.36‐fold and women by 1.36‐fold. In 2019, the prevalence of TBL cancer was approximately 57% in Asian countries. During this period, the ASPR of TBL cancer increased by 4% in men. This increase was higher (10%) in women. Also, in this period in men, ASPR decreased globally, in America and Europe and in women, this index increased globally, in Africa, and Europe; while decreasing in American countries. As the ASIR decreased in men and increased in women within this period, the ASPR increased more in women than in men (10% vs. 2%). However, there is no information about the duration of TBL cancer in men and women. In the meantime, the survival rate of TBL cancer should also be considered. Cao et al. showed that the survival rate of lung cancer is higher in women (47.3% vs. men 29.3%). 48 Therefore, the higher survival rate of TBL cancer in women may be one of the reasons for the increased ASPR in this group.

The results showed that in this period, the number of DALY of TBL cancer in men and women increased 1.23‐ and 1.34‐fold, respectively. However, the age‐standardized DALY rate in men decreased by 7% and in women increased by 1%. In men, the age‐standardized DALY rate decreased globally, in America, Europe, and Africa and women this index decreased globally and in America, but increased in Africa and was stable in Europe. Other studies showed that due to the improvement of lung cancer treatment worldwide, the age‐standardized DALY rate of TBL cancer decreased in men and women. 49 , 50 TBL cancer is still considered an important public health burden as the survival rate of this cancer is quite poor. 51 As a consequence, early screening and detection have a major role in decreasing TBL mortality. 52 , 53 According to the American Cancer Society recommendations, for people aged 55–74, low‐dose helical computed tomography (LDCT) should be done for the annual screening of lung cancer. As shown by screening programs, the incidence and mortality of lung cancer have significantly decreased. 54 , 55 Due to differences in equipment, resources, and skill of personnel, early detection rates differ, and to improve the detection rate, skilled personnel as well as the latest tools and equipment must be used.

In conclusion, most of the global burden of lung cancer occurs in Asian countries, and the decreasing trend of incidence, death, prevalence, and burden of this cancer in these countries is slower than in other regions. Therefore, the implementation of necessary measures to reduce the process of this cancer is considered urgent. These plans should include reducing the risk factors exposure, starting or expanding the screening and diagnostic programs especially for high‐risk smoker men, and expanding treatment procedures.

As online data were used in this study, the possibility of errors in the stored data is a major limitation of the study, such as problems of quantifying all sources, delays in accessing data, and changes in coding practices over time, gaps in reliable cancer reporting, and registries in low‐SDI countries.

AUTHOR CONTRIBUTIONS

HS, AM, FR and LA designed and conceived the study. AM collected thedata. LA, AM, HS, and FR analyzed and interpreted the data. AM, AR, FR, LA, andHS, drafted the manuscript. HS, FR and AM provided administrative, technical,or material support. All authors contributed to the article and approved thesubmitted version.

Rezaei F, Mazidimoradi A, Rayatinejad A, Allahqoli L, Salehiniya H. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data. Thorac Cancer. 2023;14(18):1668–1706. 10.1111/1759-7714.14912

REFERENCES

  • 1. Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383(9916):549–57. [DOI] [PubMed] [Google Scholar]
  • 2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. [DOI] [PubMed] [Google Scholar]
  • 3. Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, et al. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J thorac Dis. 2016;8(6):1094–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ghoncheh M, Mohammadian M, Mohammadian‐Hafshejani A, Salehiniya H. The incidence and mortality of colorectal cancer and its relationship with the human development index in Asia. Ann Glob Health. 2016;82(5):726–37. [DOI] [PubMed] [Google Scholar]
  • 5. Arabsalmani M, Mohammadian‐Hafshejani A, Ghoncheh M, Hadadian F, Towhidi F, Vafaee K, et al. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J Nephropathol. 2017;6(1):30–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. [DOI] [PubMed] [Google Scholar]
  • 8. Ferlay J, Steliarova‐Foucher E, Lortet‐Tieulent J, Rosso S, Coebergh J‐WW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403. [DOI] [PubMed] [Google Scholar]
  • 9. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi‐Lakeh M, MacIntyre MF, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Tavargeri AK, Kulkarni SS, Sudha P. Idiopathic gingival fibromatosis—a case report. J Indian Soc Pedod Prev Dent. 2004;22(4):180–2. [PubMed] [Google Scholar]
  • 11. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100(23):1672–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Krishna KB, Raju PK, Chitturi RR, Smitha G, Vijai S, Srinivas BV. Prevalence of gingival enlargement in Karnataka school going children. J Int Oral Health. 2014;6(1):106–10. [PMC free article] [PubMed] [Google Scholar]
  • 13. Nazir M, Al‐Ansari A, Al‐Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J. 2020;2020:2146160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd‐Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kianmehr N. Update in systemic lupus erythematosus. RJMS. 2018;24(163):63–9. [Google Scholar]
  • 16. Pakzad R, Mohammadian‐Hafshejani A, Ghoncheh M, Pakzad I, Salehiniya H. The incidence and mortality of lung cancer and their relationship to development in Asia. Transl Lung Cancer Res. 2015;4(6):763–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021;25(1):45–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54. [DOI] [PubMed] [Google Scholar]
  • 19. Samet JM. Health benefits of smoking cessation. Clin Chest Med. 1991;12(4):669–79. [PubMed] [Google Scholar]
  • 20. Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Global Health. 2019;85(1):8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ning F‐L, Lyu J, Pei J‐P, Gu W‐J, Zhang N‐N, Cao S‐Y, et al. The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019. Sci Rep. 2022;12(1):5980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Mubarik S, Wang F, Fawad M, Wang Y, Ahmad I, Yu C. Trends and projections in breast cancer mortality among four Asian countries (1990–2017): Evidence from five stochastic mortality models. Sci Rep. 2020;10(1):5480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Allahqoli L, Mazidimoradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Front Oncol. 2022;12:921015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, et al. The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep. 2022;5(6):e936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I. Global, regional and national burden, incidence, and mortality of cervical cancer. Cancer Rep. 2022;6:e1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Sharma R, Abbasi‐Kangevari M, Abd‐Rabu R, Abidi H, Abu‐Gharbieh E, Acuna JM, et al. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Go DS, Kim YE, Yoon SJ. Subnational Burden of Disease According to the Sociodemographic Index in South Korea. Int J Environ Res Public Health. 2020;17(16):5788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med. 2020;9(18):e03338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Institute for Health Metrics and Evaluation . Protocol for the global burden of diseases, injuries, and risk factors study (GBD) Version 4.0. Global burden of diseases, injuries, and risk factors study. 2020.
  • 30. Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902. [DOI] [PubMed] [Google Scholar]
  • 31. Akhtar N, Bansal JG. Risk factors of lung cancer in nonsmoker. Curr Probl Cancer. 2017;41(5):328–39. [DOI] [PubMed] [Google Scholar]
  • 32. Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;26(4):779–86. [DOI] [PubMed] [Google Scholar]
  • 33. Papadopoulos A, Guida F, Leffondré K, Cénée S, Cyr D, Schmaus A, et al. Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study. Br J Cancer. 2014;110(5):1385–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Powell HA, Iyen−Omofoman B, Hubbard RB, Baldwin DR, Tata LJ. The association between smoking quantity and lung cancer in men and women. Chest. 2013;143(1):123–9. [DOI] [PubMed] [Google Scholar]
  • 35. Mollerup S, Jørgensen K, Berge G, Haugen A. Expression of estrogen receptors α and β in human lung tissue and cell lines. Lung Cancer. 2002;37(2):153–9. [DOI] [PubMed] [Google Scholar]
  • 36. Alberg AJ, Wallace K, Silvestri GA, Brock MV. Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol. 2013;177(7):613–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, et al. Hormone use, reproductive history, and risk of lung cancer: the women's health initiative studies. J Thorac Oncol. 2015;10(7):1004–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Remon J, Molina−Montes E, Majem M, Lianes P, Isla D, Garrido P, et al. Lung cancer in women: an overview with special focus on Spanish women. Clin Transl Oncol. 2014;16:517–28. [DOI] [PubMed] [Google Scholar]
  • 39. World Health Organization (WHO) . Fact sheet about health benefits of smoking cessation. WHO Tobacco Free Initiative. 2015. https://www.who.int/tobacco/quitting/benefits/en
  • 40. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Deng Y, Peng L, Li N, Zhai Z, Xiang D, Ye X, et al. Tracheal, bronchus, and lung cancer burden and related risk factors in the United States and China. Am J Transl Res. 2021;13(4):1928–51. [PMC free article] [PubMed] [Google Scholar]
  • 42. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88(3‐4):183–92. [DOI] [PubMed] [Google Scholar]
  • 43. Cohen SB‐Z, Paré PD, Man SP, Sin DD. COPD and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med. 2007;176(2):113–20. [DOI] [PubMed] [Google Scholar]
  • 44. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291(14):1763–8. [DOI] [PubMed] [Google Scholar]
  • 45. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer. 2002;87(1):43–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Kligerman S, White C. Epidemiology of lung cancer in women: risk factors, survival, and screening. AJR Am J Roentgenol. 2011;196(2):287–95. [DOI] [PubMed] [Google Scholar]
  • 47. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers—a different disease. Nat Rev Cancer. 2007;7(10):778–90. [DOI] [PubMed] [Google Scholar]
  • 48. Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, et al. Scientific advances in lung cancer 2015. J Thorac Oncol. 2016;11(5):613–38. [DOI] [PubMed] [Google Scholar]
  • 50. Wu L, Leng D, Cun D, Foged C, Yang M. Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens. J Control Release. 2017;260:78–91. [DOI] [PubMed] [Google Scholar]
  • 51. Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, et al. Progress in cancer survival, mortality, and incidence in seven high−income countries 1995–2014 (ICBP SURVMARK−2): a population‐based study. Lancet Oncol. 2019;20(11):1493–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Oudkerk M, Liu S, Heuvelmans MA, Walter JE, Field JK. Lung cancer LDCT screening and mortality reduction—evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18(3):135–51. [DOI] [PubMed] [Google Scholar]
  • 53. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung‐cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13. [DOI] [PubMed] [Google Scholar]
  • 54. National Lung Screening Trial Research Team , Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, et al. Results of initial low‐dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368(21):1980–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2014;21(1):9–14. [DOI] [PubMed] [Google Scholar]

Articles from Thoracic Cancer are provided here courtesy of Wiley

RESOURCES